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ABSTRACT
LINK BETWEEN MUSCLE AND WHOLE-BODY ENERGETIC RESPONSE TO
EXERCISE
MAY 2021
CHRISTOPHER HAYDEN, B.S., SPRINGFIELD COLLEGE,
M.S., UNIVERSITY OF MASSACUSETTS AMHERST
Directed by: Professor Jane A. Kent
Substantial evidence exists regarding how skeletal muscles use energy and how
this affects muscular performance. What remains unclear is how characteristics of muscle
energetics affect whole-body energetics during daily living, and what effects this may
have on mobility. The goal of this study was to determine the associations between
muscle and whole-body energetics including the relationships between: 1) muscle PCr
depletion (∆PCr) in response to light intensity isotonic contractions and the oxygen
deficit at the onset of a 30-min treadmill walk (30MTW), and, 2) muscle oxidative
capacity and excess post-exercise oxygen consumption (EPOC; 30MTW), respiratory
exchange ratio (RER; 30MTW), and peak oxygen consumption (VO2 peak) from a
graded treadmill test. Eight healthy young (28.4 ± 3.5 years) male participants were
studied. Muscle energetics were measured via 31-Phosphorus magnetic resonance
spectroscopy (31P-MRS). Muscle ∆PCr was determined as the change in PCr during 2min of isotonic knee extensor contractions. Muscle oxidative capacity was determined as
the rate constant (kPCr) of a PCr recovery following 24-s of maximal isokinetic knee
extensor contractions. Whole-body energetic responses to the 30MTW were measured
via indirect calorimetry. Oxygen deficit and EPOC were determined as the time constants
v

of the change in oxygen consumption at the onset and offset of the 30MTW, respectively.
Respiratory exchange ratio was determined as the mean RER during minutes 7-30 (RER
L23), 25-30 (RER L5), and 29-30 (RER L1). Peak oxygen consumption was the highest
30-s average of oxygen consumption during a graded treadmill test, normalized to total
mass and lean mass measured by dual-X-ray absorptiometry. Spearman rank correlation
coefficients (rs) were calculated to evaluate the associations between independent
variables (muscle ∆PCr and oxidative capacity) and dependent variables (oxygen deficit,
EPOC, RER, and VO2 peak). Muscle ∆PCr had a positive association (rs = 0.46, p = 0.30)
with oxygen deficit. Muscle oxidative capacity had a negative association with EPOC (rs
= -0.64, p = 0.14), RER L23 (rs = -0.64, p = 0.14), L5 (rs = -0.68, p = 0.11), and L1 (rs = 0.74, p = 0.07). Muscle oxidative capacity had a positive association with VO2 peak per
lean mass (rs = 0.64, p = 0.10), but not VO2 peak per total mass (rs = 0.14, p = 0.75).
These results provide promising preliminary evidence that muscle energetics are
associated with whole-body energetic response to daily-living type exercise.
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CHAPTER 1
INTRODUCTION
Presentation of the Problem
Mobility can be defined as the ability to move freely and easily. A decline in
mobility-related function (i.e., the capacity to complete mobility tasks) poses a significant
threat to the quality of life in multiple segments of the population, including those who
are elderly, diseased, or disabled (27, 35, 85). Many physiological systems contribute to
mobility, but the production of movement is the primary function of skeletal muscle. In
particular, skeletal muscle converts chemical energy into mechanical energy, which
enables muscles to contract and create bodily motion. To produce and sustain movement,
muscle energy production must increase several orders of magnitude above its resting
level. This high energy requirement makes adequate energy production vital to mobility
(103). The general study of how organisms derive and use energy is termed
bioenergetics. Bioenergetic research, as it relates to movement, is often performed at
either the muscle (in vitro, in situ, or in vivo) or the whole-body level (24, 29, 30, 34, 49,
71, 78, 97, 108). The study proposed here will evaluate both.
Historically, our lab has used 31phosphorus magnetic resonance spectroscopy (31PMRS) to investigate the effects of aging and physical activity on muscle energetics and
fatigue in vivo, with the goal of improving mobility and increasing quality of life. We
have demonstrated that aging and physical activity are related to altered muscle oxidative
capacity (36, 70), glycolytic flux (66, 69), and the accumulation of fatiguing metabolites
(66, 69). Although it is clear that muscle energetics are important for mobility,
determining the effect of altered muscle energetics on mobility-related function proves
1

difficult. This is largely because the most effective way to measure muscle energetics,
31

P-MRS, is limited to the confines of a magnetic resonance scanner and cannot be used

during mobility tasks (Fig. 1). One potential solution lies in the measurement of wholebody energetics, which can be completed during mobility tasks, and is related to indices
of mobility-related function (4, 9, 15, 92, 98, 99). Whole-body energetics is largely
dependent on muscle energy demand (21, 93, 94, 110), and could potentially act as an
intermediate pathway through which muscle energetics affects mobility-related function
(Fig. 2). Therefore, the goal of this project is to analyze the relationship between muscle
and whole-body energetics; during the completion of and recovery from daily-living type
exercise.

Figure 1. Experimental set up for 31P-MRS analysis of muscle
energetics. (50)

Figure 2. Study focus

2

Background
ATP: The Primary Energy Source
Energy cannot be created or destroyed, only transferred. In living organisms,
chemical energy is transferred into mechanical energy to complete tasks such as
contracting muscle. Humans derive this chemical energy from food; the majority comes
from carbohydrate and fat sources and a small portion comes from protein (106). These
three substances are considered macronutrients and serve as substrates for energyproducing chemical reactions (energy metabolism). The amount that each substrate
contributes to energy production is termed substrate use. Through the breakdown of
macronutrients, the body generates adenosine triphosphate (ATP), which is a small
molecule that can both store and transfer chemical energy. Energy transferred through
ATP is used by the body to transmit signals, transport ions, contract muscles, build and
breakdown substances, and drive chemical reactions, among other functions.
To release energy from ATP, one of the three phosphates is cleaved off by an
enzyme, producing adenosine diphosphate (ADP) and inorganic phosphate (Pi) and
releasing energy as a byproduct. Phosphate-cleaving enzymes (ATPases) can serve many
functions, and how the released energy is used depends on the enzyme involved. In
muscle, for example, myosin acts as an ATPase by splitting ATP and using the energy
released to complete a “powerstroke” causing muscle to contract. Without ATP, vital
enzymes would not be able to complete their functions and living organisms would
quickly perish. Thus, the production of ATP is one of the most important processes of the
human body (90).
There are three main pathways through which ATP is generated: the
phosphocreatine (PCr) system, glycolysis, and oxidative metabolism (consisting of the
3

Krebs cycle and oxidative phosphorylation). The first two pathways can generate energy
without the use of oxygen and are collectively referred to as non-oxidative metabolism.
Conversely, oxidative metabolism can only occur when oxygen is available. Cells rely on
different pathways based on their needs, function, structure, and enzymatic makeup. In
human cells, non-oxidative metabolism occurs in the cytoplasm and oxidative
metabolism occurs in the mitochondria. All three energy pathways contribute to ATP
generation at all times, however, the relative contribution of each varies due to
differences in rate, duration, and the conditions under which they can provide energy
(55). As shown in Fig. 3 the maximal rate of ATP generation and the amount of ATP that
can be derived from the body’s energy stores differs for each pathway.

Figure 3. Maximal energy rates and availability from different pathways. (55)
The PCr system consists of a single-step reaction that transfers a phosphate from
PCr to ADP, resulting in the synthesis of ATP and creatine (Cr). Cells have limited stores
of PCr (~15 s worth), but the simplicity of the reaction allows for very rapid energy
production (Fig. 3).
Glycolysis is a slightly more complex process involving ten chemical reactions
that break down carbohydrate (glucose or glycogen) into smaller intermediate molecules
4

eventually producing pyruvate, NADH (an energy shuttle), and ATP. Only the ATP can
be used directly for energy, while the pyruvate and NADH can be sent into the
mitochondria for use in oxidative metabolism. For this reason, glycolysis is a nonoxidative source of ATP). The amount of energy that can be produced by glycolysis from
carbohydrate stores is more than that from the PCr system (Fig. 3) but is still only
sufficient for short-duration exercise (~1 min). The rate of glycolytic ATP generation is
slower than the PCr system but faster than oxidative metabolism (Fig. 3).
Oxidative metabolism is made up of two multi-step processes; the Krebs cycle
and oxidative phosphorylation. The products of either glycolysis or beta-oxidation (the
breakdown of fat) enter the Krebs cycle and oxidative phosphorylation where they are
further metabolized, eventually producing ATP, carbon dioxide (CO2), and water.
Oxidative metabolism generates ATP at a slower rate than the PCr system or glycolysis;
however, it can use carbohydrate, fat, or protein as substrates. For this reason, the
duration that ATP can be produced oxidatively from the body’s substrate stores is on the
order of days. Oxidative metabolism also generates the largest amount of ATP per
substrate consumed- roughly 15-52 times that of glycolysis depending on the substrate
used- making it the most efficient in terms of energy per gram of fuel (55).
31

P-MRS: A Window into Muscle ATP Production
In skeletal muscle, the rate that PCr, glycolysis and oxidative metabolism produce

ATP can be observed using 31P-MRS. This technique is a non-invasive method that uses
radio waves in the presence of a static magnetic field to determine the concentration of
31

P-containing chemical compounds within the body. Typical 31P-MRS measurements

include quantitation of: ATP flux through each pathway, oxidative capacity (i.e.,
5

maximal rate), metabolic economy, and intracellular acidification in response to muscle
contractions. A muscle’s ability to generate force and power over time is dependent on
adequate energy production, from sustainable pathways, for the entirety of the exercise.
Analysis of energetics has shown that at the onset of exercise (muscle
contractions) muscle first relies on the PCr system to provide immediate energy. Muscle
stores of PCr decline at a rate relative to the energy demand and would quickly deplete
without the additional contribution from the other two systems. Glycolysis will assist first
because the rate of energy production can be increased rapidly to meet energy demands.
At low-moderate intensity, after there has been enough time for its rate to increase,
energy reliance will then shift mainly to oxidative metabolism. At higher intensities,
glycolysis will continue to provide the majority of energy, because oxidative metabolism
cannot produce ATP at a sufficient rate (47, 102, 103). However, high rates of glycolysis
are also associated with increased muscle fatigue (decrease in force or power production)
and are therefore likely to shorten the duration that contractions can be performed (108).
After contractions cease, PCr stores that were depleted at the onset of exercise will be
replenished by ATP generated through oxidative metabolism. A muscle’s oxidative
capacity can be estimated by measuring the rate of PCr recovery after a PCr-depleting
bout of exercise (57). This is a measure of the muscle's maximal ability to generate
energy through oxidative metabolism and is dependent on mitochondrial content, quality,
enzyme content, as well as muscle capillary density, and oxygen (O2) perfusion. After
exercise, other metabolites that accumulated during the contractions (H+, ADP, and Pi)
will also return to baseline levels; hence this period is referred to as recovery (81, 87).

6

Indirect Calorimetry: A Window into Whole-body Energetics
Indirect calorimetry is a respirometry technique that estimates energy expenditure
via measurement of O2 and CO2 expired from the lungs. This gas exchange is
representative of the O2 consumption and CO2 production of the entire body because all
blood is eventually circulated to the lungs to allow gas exchange with air from the
environment. In contrast to the muscle level, analysis of whole-body energetics through
the use of indirect calorimetry allows for the evaluation of oxidative energy production
only. Currently, there are no direct methods to determine the contribution of the PCr or
glycolytic pathways to whole-body energy expenditure. Common variables assessed
using indirect calorimetry include: the energetic cost of a task, oxygen uptake kinetics at
exercise onset (“on” kinetics), oxygen uptake kinetics at the end of an exercise (“off”
kinetics), and substrate use throughout exercise (grams oxidized per substrate). Similar to
the measurement of muscle oxidative capacity, graded exercise tests can be used to
determine the maximal rate of oxidative metabolism at the whole-body level (VO2 peak).
The same traits associated with high oxidative capacity in muscle are also associated with
smaller and shorter O2 deficits (on kinetics) and excess post-exercise oxygen
consumptions (EPOCs; off kinetics) and increased use of fats during higher-intensity
exercise (90).
At the beginning of a given exercise bout, energy demand increases
instantaneously to a level dependent on the activity. Oxidative energy production,
however, cannot increase instantaneously and will slowly rise to meet energy demand.
The difference between the actual O2 consumption and the amount required to meet
demand is termed the O2 deficit (Fig. 4). While in a state of O2 deficit, the non-oxidative
7

pathways (PCr and glycolysis) provide the remainder of energy needed to perform the
task.

Figure 4. Oxygen consumption response to moderate-intensity
exercise. (32)
At low-moderate exercise intensities, oxidative energy production will eventually
meet demand and O2 consumption will plateau. This is called steady-state, during this
time the energy systems have reached equilibrium, and oxidative metabolism is assumed
to be the main provider of energy (Fig. 4) (40). Once a steady-state is reached, the rate of
carbohydrate and fat use can be estimated, as can energy cost of the activity (kcals). At
high exercise intensities, oxidative energy production is never able to fully meet demand,
and oxygen consumption will not plateau. This is not considered steady-state and the
relative contribution of each pathway is unclear.
Post-exercise recovery is the process of the body returning to homeostasis. During
recovery from exercise, oxygen consumption (and therefore energy expenditure) remains
elevated above resting levels for a period of time even though the direct energy demand
8

of the exercise has ceased. This period is called the EPOC and can be broken into a fast
(initial rapid decrease in O2 consumption) and a slow (prolonged low-level elevation of
O2 consumption) component (Fig. 4). The excess O2 consumed during the fast component
is believed to contribute to the replenishment of hemoglobin and myoglobin oxygen
stores (within seconds) and the oxidative regeneration of PCr to resting levels (within
minutes). The excess O2 consumed during the slow component is believed to be required
due to the residual elevation in ventilation and heart rate, lactate’s oxidation or
conversion to glucose, glycogen re-synthesis, an increased rate of metabolism due to
elevated temperature and catecholamine levels, re-establishment of ionic equilibrium, and
potentially an increased protein turnover (38, 40).
There are two primary modes of indirect calorimetry; measurement of gas
exchange by a metabolic cart or by a room calorimeter (also referred to as a metabolic
chamber). Metabolic carts can allow for breath-by-breath analysis of respiration and
therefore have a very fine temporal resolution. This technique requires the participant to
wear a mask or a mouthpiece connected to a stationary cart or a backpack, which can be
cumbersome, and uncomfortable. This makes them unsuitable for detecting small, longduration changes in metabolism, and are typically only used for short-term analyses (<3
hr). Room calorimeters have a lower temporal resolution but do not require the use of
masks or bulky equipment. In a room calorimeter, the participant is able to eat meals,
exercise, and sleep while gas exchange is measured continuously. This allows for longterm (multi-day) metabolic analyses in an environment that more closely resembles freeliving.

9

Connecting Muscle to Whole-body Energetics
While the energetics of a single muscle can be observed through 31P-MRS,
movement requires the energetic contributions of multiple muscles and physiological
systems. Together, the energy requirements of muscular, cardiovascular, neural, and
respiratory components of the body contribute to the cost of physical activity energy
expenditure. However, muscle makes up 20-30% of energy expenditure at rest and up to
90% during exercise, and therefore, should have a large impact on metabolic variables
observed during whole-body energy expenditure (110). The vastus lateralis (VL), a large
muscle located on the anterior-lateral portion of the thigh, is one of the more common
muscles studied using 31P-MRS. The VL helps to extend the leg at the knee and plays an
important role in ambulation during both the swing and support phase of gait (22, 76). It
is activated during gait in a similar manner to the vasti medialis and intermedius, which
contribute to gait increasingly as walking speed increases and make up the majority of the
quadriceps muscles (76, 86). Due to the VL’s significant role in ambulation, its energetic
characteristics are likely to affect whole-body energy expenditure during mobility tasks.
Oxygen Deficit
At the onset of exercise, during the O2 deficit, non-oxidative sources must
compensate for the difference between energy demand and oxidative energy supply.
While it is not currently possible to quantify the non-oxidative contribution at the wholebody level, it is possible to estimate non-oxidative ATP production in a single muscle. If
an individual’s VL has a high reliance on non-oxidative pathways and is slow to increase
oxidative energy production, then it is likely to coincide with a greater oxygen deficit
during whole-body exercise that relies heavily on the VL and like muscles.

10

Maximal Oxygen Consumption
The maximal rate of oxidative energy production can be measured at both the
single muscle and whole-body levels as oxidative capacity and VO2 max, respectively.
Maximal oxygen consumption is approached during forms of exercise that require
significant work from a large amount of muscle mass. Therefore, it is likely that the
oxidative capacity of large muscles such as the VL would have a considerable impact on
an individual’s VO2 max, which has been demonstrated previously (111).
Excess Post-exercise Oxygen Consumption
During recovery, extra energy (above resting) is required to return the body to
homeostasis; this energy is produced via oxidative metabolism. This process can be
observed at the whole-body level through the measurement of EPOC, a significant
portion of which allows for the re-synthesis of muscle PCr. Therefore, a high muscle
oxidative capacity may enable faster recovery from exercise and a shorter EPOC (63).
Substrate Use
Although 31P-MRS can be used to measure the rate of oxidative energy
production it cannot be used to determine substrate use (fat vs. carbohydrate use).
However, substrate use can be estimated with indirect calorimetry using the respiratory
exchange ratio (RER). Studies of substrate use during exercise have shown that at low
intensities the body relies more on fat as an oxidative fuel source, but shifts to
carbohydrates use as intensity increases (51). This occurs because carbohydrates can be
used by oxidative pathways at a faster rate than fat. Studies have also shown that
aerobically trained individuals will continue to rely on fat at higher relative and absolute
intensities than their untrained counterparts (4). The same adaptations that occur with
aerobic training, an increase in mitochondrial and capillary density, are also responsible
11

for increases in muscle oxidative capacity. Individuals with a greater oxidative capacity
may then be more reliant on fat at any given intensity.
The Gap in Knowledge and Proposed Solution
Researchers have suggested that both single-muscle and whole-body energetics
affect free-living daily function through changes in fatigue, fatigability, mobility, and
physical activity (4, 9, 23, 24, 30, 92, 97-99, 108). While connections between muscle
and whole-body energetic characteristics may appear relatively straightforward, few
studies have attempted to evaluate the connection between the two in a comprehensive
manner that is applicable to free living. One study by Rossiter et al. (93) measured
muscle and whole-body energetics simultaneously during rhythmic alternating knee
extensions. A direct association was shown between energy consumption measured at the
muscle and whole-body level. However, the isolated non-ambulatory exercise used in the
Rossiter et al. study is significantly different from normal activities of daily living.
Another study by Hunter et al., in 2006, attempted to relate muscle metabolic function to
free-living energy expenditure and physical activity. This study used a combination of
room calorimetry and doubly-labeled water for estimation of free-living energy
expenditure and activity levels. However, the precise physical activities, their time
course, and the characteristics of O2 deficit, substrate use, and EPOC could not be
analyzed, as only the sum of two weeks of energy expenditure was recorded (48). To the
best of the author’s knowledge, a study has yet to be performed that evaluates the
connection between high-resolution, whole-body energetics during free-living activities
and muscle energetic characteristics during contractions of comparable intensity.
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To fully understand the impact of alterations in muscle energetics on mobilityrelated function, their relation to whole-body energetics during mobility activities must
be determined. For this reason, this study will consist of a comprehensive analysis of
muscle and whole-body energetic responses to exercise, and then evaluate potential links
between them. Completion of this project will advance the field by providing evidence
that whole-body energetics can be used as a reliable intermediary point between muscle
energetics and mobility-related function.
Specific Aims
With the above stated, the aims of the proposed research are:
Aim 1. Evaluate the relationships between muscle ∆PCr in response to light intensity
(6% MVIC) isotonic contractions and the O2 deficit at the onset of a standardized
treadmill walk.
Hypothesis 1. There will be a positive association between muscle ∆PCr and O2
deficit because reliance on non-oxidative energy sources (∆PCr) is and indicator that the
ATP need not being met through oxidative metabolism. Therefore, those who rely more
on PCr likely do so because it takes longer for them to increase oxidative energy
production to meet demand at exercise onset (O2 deficit).
Aim 2. Evaluate the relationships between muscle oxidative capacity and; EPOC and
RER in response to a treadmill walk, and VO2 peak from a graded maximal exercise test.
Hypothesis 2.1. There will be a negative association between muscle oxidative
capacity and EPOC because a greater ability to produce energy oxidatively will result in
less depletion of PCr and creation of lactate at the start of exercise, and, faster repletion
of PCr and oxidation of lactate following exercise, both of which should result in a
shorter EPOC time constant.
Hypothesis 2.2. There will be a negative association between muscle oxidative
capacity and RER because a greater ability to produce energy oxidatively would
decrease the relative intensity of a standardized exercise, and, is related to an increased
ability to use fat as a fuel source, both of which are related to a greater reliance on fat
and therefore a lower RER.
Hypothesis 2.3. There will be a positive association between muscle oxidative
capacity and VO2 peak because they are indicators of the maximal ability of the muscle’s
13

and the whole-body to consume oxygen, and muscle consumes the majority of the body’s
oxygen during maximal exercise.
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CHAPTER 2
LITERATURE REVIEW
The purpose of this thesis is to connect two common forms of bioenergetic
analysis in a way that will be useful in future research in the realm of aging, physical
inactivity, and mobility-related function. Because the primary goal is to provide strong
evidence of the relationship between energetic characteristics measured at the muscle and
the whole-body levels, it is necessary that the techniques used, as well as their
physiological significance, are understood. For this reason, this literature review will start
with a relatively in-depth review of the methods and measurements that are the focus of
this study. This review will be followed by a more succinct review of the literature
regarding this study’s motivation and justification.
Introduction of Measurements
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Phophorus Magnetic Resonance Spectroscopy
Magnetic resonance spectroscopy (MRS) is a method that that takes advantage of

sub-atomic nuclear properties to determine the chemical composition of a given sample
without the need to physically disrupt it or interfere with its function (i.e., noninvasively).
Discussed here is 31Phosphorus-MRS (31P-MRS) as it is used in human bioenergetic
research to determine the concentration of 31P containing chemical compounds within the
body. Analysis of these compounds allows for the observation of energy production and
consumption in the body. There are many metabolically important 31P containing
chemicals in the body, but the ones most commonly measured are inorganic phosphate
(Pi), phosphocreatine (PCr), and adenosine triphosphate (ATP). During human 31P-MRS,
a participant is put inside a magnetic resonance scanner where they are exposed to a
15

strong static magnetic field, and radio wave signals are sent into the body. The energy
from these radio waves will be absorbed by 31P atoms, which will then re-emit signals
that can be detected by the scanner. These signals are emitted at specific frequencies,
called resonant frequencies. Different frequency signals will be emitted based upon the
characteristics of the molecule that the 31P atom is bound to. The amount of signal at a
certain frequency is based on the amount of a particular chemical in the sample, and it is
from these signals that chemical concentrations are derived.
The output of this technique is a graph with frequency on the x-axis and
amplitude on the y-axis. Peaks at different frequencies represent the 31P signal from
specific molecules and the amplitude of each peak represents the relative concentration of
that molecule. This graph is known as a spectrum and an example can be seen in Fig. 5.
In this spectra obtained from skeletal muscle peaks for Pi, PCr, and ATP are easily
observable. There are three peaks for the ATP signal because there are three 31P atoms in
ATP, each of which resonates at a slightly different frequency due to its position and
surroundings in the molecule (Fig. 6).
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Figure 5. 31P-MRS spectrum from resting muscle. (57)

Figure 6. Labeled structure of ATP (Wikimedia Commons)
The use of 31P-MRS to investigate phosphorus-containing chemicals began in
1960 when Cohn and Hughes successfully observed multiple 31P peaks in solutions of
both ADP and ATP. In the same study, they also demonstrated an important
characteristic of MRS known as a chemical shift. A chemical shift is a change in the
resonance frequency of an atom due to a change in the chemical environment, which in
this case was altered pH. As seen in Fig. 7, when exposed to extremely low pH (3.60), the
alpha (ά) and gamma (γ) 31P peaks in ATP shift to both resonate at a similar frequency
17

and appear to merge into one signal. Measurement of particular chemical shifts in 31PMRS signals became of great importance in the years to follow (25).

Figure 7. The chemical shift in ATP Adapted from. (25)

In the 1970s scientists began using 31P-MRS to investigate biological tissue (77).
By the mid 70’s Burt and colleagues (among others) brought the technique to the study of
excised intact skeletal muscle, where they were able to resolve clear peaks for Pi, PCr,
and the three phosphates of ATP, as well as several other metabolites. Since these
experiments were conducted in live intact muscle, it became possible to observe how the
concentration of metabolites changed over time, greatly increasing the efficacy of using
this technique to investigate energetics (see Fig. 8).
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Figure 8. Change in concentrations of phosphorus
metabolites as detected by 31P-MRS. (16)

Through several titration experiments, it was also observed that Pi had a
significant chemical shift across a physiologically relevant pH range (7.5 – 6.0 pH), but
PCr and ATP did not (Fig. 9). This was an important discovery because it showed that the
chemical shift of Pi could be used to accurately estimate the pH of intact muscle without
the need for invasive measurements. The concept of which is as follows; because a
change in pH across a normal physiological range causes a consistent and repeatable
change in the resonance frequency of Pi, that resonance frequency can then be used to
back-calculate pH (16).
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Physiological pH
Range

Figure 9. The chemical shift of various relevant phosphate
compounds as a function of pH Adapted from (16)
In 1978 Dawson, Gadian and Wilkie pioneered techniques that allowed them to
investigate the energetics of muscle fatigue (i.e., a decline in force production) in
contracting muscle. By attaching a strain gauge to a sample of excised frog muscle inside
a spectrometer (an MRS device) and stimulating it with electrodes, they completed one of
the first 31P-MRS analyses of live contracting muscle. From this, the energetic cost of
force development was calculated and it was found that muscle fatigue was proportional
to H+ and ADP accumulation, but not to decreases in ATP or PCr. This suggested that
muscle fatigue was likely due not to a lack of available energy, but rather inhibition
caused by the buildup of metabolites. It was also observed that as less force was produced
less ATP was used, suggesting that the production of force has a fixed cost and that the
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economy of ATP hydrolysis is relatively stable. These findings demonstrated the
potential power of 31P-MRS and helped set the stage for years of muscle fatigue research
to follow (28). A large breakthrough was made two years later by Ackerman et al. when
they created an instrument called a ‘surface coil’ which when used in conjunction with
standard MRS equipment greatly enhanced spatial resolution. Until this point, it was not
possible to select a region of interest when scanning a sample, meaning that to study a
specific tissue or organ it would first have to be removed from the organism. Utilizing
this new tool Ackerman et al. became the first team to obtain 31P-MRS spectra in animal
muscle and brain in vivo. This breakthrough was of great importance because it opened
the door for the use of MRS techniques in human muscle without the need for any
invasive procedures (e.g., biopsies) (1). In the years since methods have continued to
improve and MRS has become one of the most important tools used in the study of
human bioenergetics.
Work with MRS has allowed scientists, in the words of Doris Taylor, to “define
those features of muscle metabolism that are relatively invariant in healthy subjects” to
enable the “diagnosis and understanding of different disorders of the locomotor system”
(102). Some of these important features include the following. At the beginning of
submaximal exercise PCr concentrations in muscle decline proportionally to work rate,
but will reach a steady-state with a similar time constant (Fig. 10 B.) (6, 81). The rate of
glycolysis will increase to assist in ATP production during contraction but not does
contribute significantly to ATP or PCr synthesis during recovery (91, 102). Intracellular
pH will decrease more with increasing work intensities and in relation to an increased
rate of glycolysis (6, 17, 103). The creatine kinase (CK) reaction is maintained near21

equilibrium during submaximal contractions, which allows for the calculation of ADP
concentrations (6, 103). Oxidative energy production is the major source of energy during
light steady-state exercise and is solely responsible for the re-synthesis of PCr after
exercise (Fig. 10 A.) (91, 102).

Figure 10. Muscle energetics responses to exercise, A) followed by ischemia, B)
in response to various work rates. A) The 4 lower curves represent the intracellular
pH of four participants. The upper top curve represents the PCr changes in
participants 1-3 (open circle) and 4 (closed circle). B) Each curve represents the PCr
response to repetitive muscle stimulation at increasing intensity representing 0.25,
0.50, and 0.75 Hz (A: (34), B: (38)).
With the knowledge of these and other basic features of skeletal muscle
metabolism researchers have developed several measures that vary across subjects and
can be used as indicators of energetic function. The two measures that are important to
this study’s aims are muscle oxidative capacity and non-oxidative ATP flux and are
discussed further here.
Oxidative Capacity
Muscle oxidative capacity is a measure of the maximal rate of oxidative ATP
production by the mitochondria. For this reason, muscle oxidative capacity can serve as a
measure of mitochondrial function. Indeed, a higher oxidative capacity is associated with
endurance training and physical activity and is likely a result of increased mitochondrial
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content and oxidative enzyme activity (70). During exercise, PCr acts as a cellular buffer
to transiently maintain ATP concentrations until demand can be met by glycolysis or
oxidative metabolism. To complete this PCr donates a phosphate to ADP producing ATP
and free creatine. In times of low energy demand, free creatine is then used to
resynthesize PCr with the donation of a phosphate from oxidatively generated ATP, (Fig.
11).

Figure 11. Mechanisms of phosphate transfer in
the cell. (20)
Oxidative capacity is estimated using PCr recovery rate after a bout of
contractions that decrease its concentration by ~50%, without altering pH or ATP levels.
This is based on the observation that PCr is replenished after exercise almost exclusively
by the oxidative pathway and follows a monoexponential trajectory (81, 91, 102). The
use of this 31P-MRS measurement of mitochondrial function has been validated against in
23

vitro respiration measures and when applied appropriately is both accurate and precise
(67, 72).
Non-Oxidative ATP Flux
As previously stated, any time that oxidative energy production cannot meet
demand the non-oxidative energy pathways will generate the remainder of ATP needed.
This is particularly important during the onset of exercise due to the slow response time
of oxidative metabolism, as seen in see Fig. 12 (54).

Figure 12. Time course for the rates of PCr depletion a),
glycolysis b), and oxidative metabolism c), in skeletal muscle
at three different workloads. (54)
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This flux of ATP is proportional to the intensity of the exercise and the time
constant for the rise in oxidative metabolism (54). Non-oxidative ATP flux is contributed
to by both the PCr and glycolytic pathways. The rate of non-oxidative metabolism is
important as higher rates are associated with greater fatigue and slower recovery (28,
103). The generation of ATP from PCr can be measured directly from the change in
concentration of PCr. Glycolytic ATP generation is estimated using its stoichiometric
relation to proton (H+) production. Proton production is measured using the chemical
shift as discussed earlier (16, 28, 102). A portion of the protons generated from glycolysis
is either excreted from the cell or buffered by intracellular chemicals. This means that the
pH of the muscle does not fully reflect the proton generation and an additional calculation
must be used to account for the proton buffering capacity of the cell (28). Many different
methods exist for these calculations so they are not included here.
Indirect Calorimetry
Humans derive energy through a series of reactions that release stored energy
from the chemical bonds in the food they consume. During this process, whether it be
oxidative on non-oxidative, heat is produced. Direct calorimetry is the measurement of
this heat production, which is proportional to the summed energy expenditure from
oxidative and non-oxidative metabolism. Due to this, direct calorimetry can be used in
biological research to measure the energy expenditure of various organisms and has been
applied to the study of human energetics since the 18th century. The basis for a direct
calorimeter is simple. It is a device (usually a sealed chamber) that measures the change
in temperature of its contents. However, the implementation of these devices is far more
complex. Direct calorimeters that can be used for human research must be rather large
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and are expensive, low in temporal resolution, and have limitations that make them
undesirable for the study of exercise. An alternative technique for human metabolic
analysis is indirect calorimetry. Indirect calorimetry is a method that uses measurements
of O2 gas consumption and CO2 gas production to estimate energy expenditure (Fig. 13).

Figure 13. The relationship between direct and
indirect calorimetry. (56)
As mentioned earlier, all human energy is originally derived from food and the
breakdown of this food releases energy and heat. An important aspect of this breakdown
(catabolism) is that when energy is derived oxidatively, a specific amount of O2 is
consumed and CO2 is produced, depending on the substrate that is involved (particularly
carbohydrate or fat). The amount of energy expended as well as the food source that it
comes from can then be calculated using measurements of gas exchange by observing the
sum and the ratio of O2 consumed to CO2 produced (Fig. 14).

Figure 14. Stoichiometry of carbohydrate and fat catabolism.
Adapted from (51).
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Compared to direct calorimetry this method is less expensive, has better time
resolution, and can be used to estimate energy expenditure during exercise as well as the
amount of carbohydrate and fat used (i.e., substrate use). Indirect calorimetry equipment
measures the gas exchange between an organism’s lungs and the environment and may
come in the form of masks, ventilated hoods, and whole-room chambers (Fig. 15). A
major drawback of indirect calorimetry is that it only measures energy expenditure
related to oxidative metabolism, although the size of the O2 deficit can be used to
estimate relative the contribution of non-oxidative metabolism. Despite this, it is
currently the most popular calorimetric technique used to analyze human energy
metabolism (56).

Figure 15. Methods of indirect calorimetry. From left to right Hans-Rudolph
mask, ventilated hood, whole-room chamber.
Indirect calorimetry was developed during the early 1800s and was validated
against direct calorimeter in animal studies. While the basis of indirect calorimetry is
slightly more complex than direct calorimetry, most information gained from this
technique comes from three outputs: volume of O2 consumed (VO2), the volume of CO2
produced (VCO2), and the ratio between the two (RER). Just before the start of the 20th
century, the Atwater-Rosa calorimeter became the first device to simultaneously measure
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direct and indirect calorimetry. Studies from this chamber verified that indirect
calorimeter measures in humans were proportional to direct calorimeter measures, and
were, therefore, an appropriate technique for studying human energetics (7). In the years
to follow indirect calorimeters became popular research instruments and many
improvements were made to the devices and techniques used to analyze their data (83). In
particular, two important equations were developed in the early 1900s that have almost
ubiquitous use in the field.
The first is called the Haldane Transform, which was developed by John Haldane
and Joseph Graham in 1912. This equation allows for the estimation of inspired volume
(VI) using the measured expired volume (VE) and the concentrations of exchanged gases.
During indirect calorimetry, gas concentrations are measured as fractions of the total air
sampled during inspiration (fraction inspired ‘FI’) and expiration (fraction expired ‘FE’).
The composition of ambient air is typically ~78% nitrogen, ~21% oxygen, and ~.04%
carbon dioxide (values which are sometimes substituted for direct measurement of
inspired air). Since gas concentration measurements are fractions they are meaningless
until multiplied by the absolute volume of air exchanged (i.e., VI and VE). This makes the
volume measurements very important in the calculations of VO2 and VCO2, as can be
seen in equations 2 and 3.
VO2 = VI ∙ FIO2 – VE ∙ FEO2
Eq. 1
VCO2 = VI ∙ FICO2 – VE ∙ FECO2
Eq. 2
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However, VI can be difficult to measure experimentally. For this reason, the Haldane
Transform can be used to estimate VI, based on the assumption that no nitrogen exchange
occurs in the lungs (a topic that is outside the scope of this review). The Haldane
Transform is as follows for the calculation of VO2, but can be used likewise for the
calculation of VCO2.

As can be seen in Eq. 3, VI has been replaced by VE multiplied by the correction factor
kH. The correction factor represents the ratio of volume inspired to volume expired. The
Haldane Transform is widely used in the field of research and has been shown to be an
accurate means of calculation when used in normal atmospheric conditions (FIO2  21%)
(65, 83).
The second important equation is related to the calculation of energy expenditure.
This equation was first described by J.B. de V. Weir in his 1949 article in the Journal of
Physiology (106). It has since come to be known as the Weir formula. One of the
desirable attributes of indirect calorimetry is that it allows the calculation of metabolic
rate (energy expended per unit time), both total and by individual substrate contribution.
Weir had recognized that it was common in metabolic research to calculate energy
expenditure (in kcals), without either measuring or correcting for protein metabolism. For
this reason, he set out to demonstrate that protein metabolism could easily be accounted
for using several simple methods. Previous works had determined the kcals produced per
liter of O2 consumed in the metabolism of carbohydrate, protein, and fat. Using these
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Weir developed a formula where protein metabolism could be estimated from urinary
nitrogen;
Total kcals = (3.941 ∙ VO2) + (1.106 ∙ VCO2) – (2.17 ∙ grams of urinary nitrogen)
Eq. 5
a formula where protein metabolism could be assigned a constant contribution p;
Total kcals = ((3.941 ∙ VO2) + (1.106 ∙ VCO2)) / (1 + .082p)
Eq. 6
and a formula where protein metabolism can be ignored with less than .2% error, so long
as protein contribution is between 10-14%;
Total kcals = ((3.9 ∙ VO2) + (1.1 ∙ VCO2))
Eq. 7
These equations remain a popular means of calculating energy expenditure today and are
directly integrated into many indirect calorimetry systems (106). The use of Eq. 7 will be
appropriate in this study as the conditions are unlikely to induce a large use of protein for
energy production.
Since 1949 numerous studies have been completed using indirect calorimetry.
Today it may be the most widely used tool in the world of exercise science. Indirect
calorimetry is a common tool in other fields as well, such as nutrition, pediatric care, and
animal research. Depending on the purpose of the experiment many different metrics may
be derived from this one measurement technique. Discussed here are important papers
regarding the main outcomes of this study: VO2 max, O2 deficit, EPOC, and substrate
use.
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VO2 Max
The maximal rate that an individual can consume O2, which is dependent on
intake, transport, and use, is termed VO2 max. The origins of this measurement lie with
the observations of Hill and Lupton in 1923 when they described the tendency of O2
consumption to increase linearly with workload until a certain point where it would
plateau despite an increase in workload (46). Consumption of O2 is reliant on the
pulmonary, cardiovascular, and muscular systems and maximal consumption is,
therefore, an indicator of the function of these combined systems (34). Specifically, the
lungs are responsible for bringing O2 into the body, which then needs to be transferred to
the blood where it is bound to hemoglobin. Once O2 is in the blood, the heart must
circulate that blood to the working tissue, where the O2 can be transferred again into the
cells. Finally, the mitochondria in the cells must be able to uptake and use the O2, to
ensure that a concentration gradient (which drives O2 transfer) is maintained. The test
itself is usually performed on a cycle ergometer or a treadmill, and the work rate is
increased gradually until the max is reached. Although it is a subject of debate, VO2 max
is generally considered to be limited by O2 delivery (SV ∙ HR) and not O2 utilization
(avO2 diff). Physical activity and exercise training can cause physiological adaptations
(Fig. 16) that improve VO2 max, which is important as this may decrease mortality risk
and improve sports performance (74, 78)
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Figure 16. Physiological adaptations that lead to an improvement in VO2
max. (78)

O2 Deficit
At the onset of exercise, energy demand increases immediately to a level
dependent on the activity intensity. The pulmonary, circulatory, and metabolic processes
required for oxidative energy production cannot increase instantaneously and will slowly
rise to meet energy demand. The difference between the actual O2 consumption and the
amount required to meet energy demand is termed O2 deficit (Fig. 17) (40). At lowmoderate exercise intensities, oxidative energy production will eventually meet demand
and O2 consumption will plateau. During a constant work rate exercise, the level of this
plateau can be used to estimate the energy demand for the entirety of exercise (red line in
Fig. 17). While in a state of O2 deficit the non-oxidative pathways (PCr and glycolysis)
provide the remainder of energy needed. This has led various researchers to suggest that
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measures of O2 deficit could be used to estimate an individual’s “anaerobic capacity” (8,
79). Deficit increases linearly with exercise intensity, meaning there is greater nonoxidative reliance at higher work-rates. Larger O2 deficits are associated with lower
exercise tolerance and earlier onset of fatigue (29). Exercise training, however, can
reduce the O2 deficit for a given workload and potentially increase exercise tolerance
(84). Physiological adaptations that lead to a decreased O2 deficit are identical to those
that improve VO2 max, including those affecting O2 delivery (i.e., cardiovascular
adaptations) and utilization (i.e., increased mitochondrial size and content, etc) (90).

Figure 17. Oxygen consumption in response to exercise over time. Adapted
from (62).
Excess Post-Exercise Oxygen Consumption
After the cessation of exercise, oxygen consumption remains elevated above
resting levels despite the apparent immediate decrease in energy demand (Fig. 17). This
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is termed excess post-exercise oxygen consumption (EPOC), and its magnitude is
proportional to both the duration and intensity of the exercise (40). Post-exercise oxygen
consumption follows an exponential curve as it recovers to baseline resting values. This
recovery curve can be broken into two components: an initial rapid decrease in O2
consumption (fast component) and a prolonged gradual decline in O2 consumption (slow
component) (Fig. 18). The excess O2 consumed during the fast component is believed to
contribute to the replenishment of hemoglobin and myoglobin oxygen stores (within
seconds) and the oxidative regeneration of PCr to resting levels (within minutes). The
excess O2 consumed during the slow component is believed to be due to the residual
elevation in ventilation and heart rate, lactate’s oxidation or conversion to glucose,
glycogen synthesis, an increased rate of metabolism due to elevated temperature and
catecholamine levels, re-establishment of ionic equilibrium, and potentially an increased
protein turnover (38, 40). The total duration of EPOC can be anywhere from a few
minutes to multiple hours. A study by Knab and colleagues showed an elevated metabolic
rate as long as 14 hr in response to a 45 min cycling bout (60). In a study examining the
effect of training status, trained participants were shown to have EPOCs that were shorter
in duration but similar in magnitude (area under the curve) when compared to untrained
participants exercising at the same relative intensity. This study also suggested the
cardiovascular and muscular adaptations that occur with exercise training and affect
oxygen delivery and utilization were responsible for the faster recovery rates due to an
increased efficiency of metabolic regulation (100). These adaptations, again, are the same
as those that improve VO2 max, and O2 deficit.
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Figure 18. Visualization of EPOC fast component (Phase 1) and
slow component (Phase 2). (38)

Substrate Use
The amount of carbohydrate, fat, or protein oxidized is termed substrate use
(because protein oxidation is minimal in most cases it will be ignored here).
Carbohydrates and fat are each oxidized in tissue with a unique ratio of CO2 consumption
to O2 production, which is called the respiratory quotient (RQ) (Fig. 14). The ratio of O2
production and CO2 consumption of an entire cell is, therefore, the average of the RQ for
all of the substrates oxidized, and can be used to determine the relative proportion of
substrate use. Because the O2 and CO2 exchange at the cells is mirrored at the lungs,
pulmonary gas exchange can be used to estimate RQ (Fig. 19a). This is done through the
measurement of the ratio of VCO2 to VO2, or the respiratory exchange ratio (RER), and
is representative of the substrate use for the whole-body. The value of RER generally
ranges from ~.7 to ~1, and each increment is associated with a percentage contribution
35

from carbohydrate and fat (Fig. 19b). Different calculations based on the setting in which
RER is measured (rest vs exercise), can then be used to determine the absolute amount of
substrate oxidized (51). The use of RER has been validated through a carbon isotope
exchange technique, and was shown to be a valid measure at steady-state intensities up to
75% of VO2 max, but not valid during higher intensities or work-to-rest transitions (51).

a.

b.

Figure 19. a.) Gas exchange at the cells and lungs; b.) Caloric values of O2 and
CO2 for non-protein RQ and proportions of substrate used (a (90), b (64))
Substrate use at a given intensity is variable across the population but is relatively
invariant in an individual (51). One way to characterize substrate use in an individual is
to find their crossover point, which is the intensity at which carbohydrate oxidation
exceeds fat oxidation (Fig. 20). Training has been shown to increase fat use across
relative intensities and shift the crossover point to the right (13, 31).
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Figure 20. Crossover point and the effect of training. Adapted from (13).

Measurement Comparison
As stated at the start of this review, the goal of this thesis is to provide strong
evidence of the relationship between measured characteristics at the muscle and the
whole-body level. Now that the measures have been described it is important to note the
similarities and differences between the two methods. This is perhaps most efficiently
done through the use of a table (Table 1).
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Table 1. Comparison of 31P-MRS and Indirect Calorimetry Measures

It is also important to note that because both levels measure characteristics of
energy expenditure and reflect the acute energy demands placed on the body, they will
likely be affected similarly by physiological adaptations brought on by chronic energy
demand. For instance, during prolonged walking or running, energy demand will increase
and stress both the muscles involved (such as the VL) and other systems in the body
(such as the cardiovascular system). Stress which over time leads to adaptation. This
notion will be expanded upon in the next section, which reviews the literature directly
related to this project.
Problem to be addressed and proposed solution
Problem to be Addressed
Aging and physical inactivity leads to a decline in mobility-related function,
which includes a decrease in walking speed, postural control, and the ability to transition
from sitting to standing or walking (30, 35). Mobility limitations are associated with
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increased falls and healthcare use and expenditures, and a decreased quality of life in
older populations (27, 35, 85). Performance of mobility test such as the ‘timed up and go’
can predict all-cause mortality (12). Aging and physical inactivity are also associated
with a decline in muscle oxidative capacity, specifically in the knee extensor muscles,
which is likely detrimental to mobility-related function (Fig. 21) (2, 23, 24, 30, 36, 97,
108). However, even modest improvements in mobility-related function have been
suggested to increase physical, emotional, and social well-being in older adults (12, 95).
For these reasons, our lab has long researched age and physical activity-related changes
in muscle energetics, to support the combat of age-related declines in mobility and
physical activity (18, 36, 66, 96, 105).

*

Figure 21. The mechanistic pathway connecting aging, muscle energetics,
mobility, and health outcomes. (* indicates the relationship of interest here).
Adapted from (24).
As discussed above, the vital role and large energy requirements of muscle during
ambulatory tasks make muscle energetic function inherently important for mobility.
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Correspondingly, researchers have sought to determine the effect of decreased energetic
function on mobility performance (23, 24, 97, 108). In 2013, Coen et al. (24) were the
first to investigate the association between of three different oxidative energy measures
(in vitro mitochondrial respiratory capacity, in vivo muscle oxidative capacity, and VO2
peak) on preferred walking speed over 400 in older adults. They found that all three
energetic measures were significantly associated with preferred walking speed, such that
individuals with a lower energetic capacity tended to walk slower. Similarly, in 2016
Choi et al. (23) found that muscle oxidative capacity was positively associated with
preferred walking speed during a 1.5 min test, as well as maximal walking speed over 6
and 400 m, but not preferred walking speed over 6 m. This led them to suggest that
muscle bioenergetics may be a limiting factor for walking performance in tasks of greater
duration and intensity (23). Given the duration of a 6 m walk (< 20 s) it would seem
unlikely that muscle energetics would be a limiting factor in the absence of serious
impairment. Santanasto et al. demonstrated a positive relationship between muscle
oxidative capacity and walking speed as well, although the association fell apart for older
adults with lower physical function (mean SPPB = 7.8 ± 1.2) (97). In cases of impaired
physical function, other comorbidities such as muscle weakness, neurological disease, or
previous injury may have a larger impact than decrement in energetic function. In an
attempt to identify the mechanism by which muscle oxidative capacity affects walking,
Zane et al. (108) found that this interaction is partially mediated by muscle strength for
short-duration activities but not for long-duration activities. This finding suggests that
although during short-duration activities the effect of decreased muscle oxidative
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capacity may be confounded by decreases in muscle strength, the same does not appear to
be true for long-duration activities.
While the above studies provide robust evidence of the relationship between
muscle energetics and mobility in a large sample of older adults (total n=551), they are
largely limited to the measurement of one in vivo energetic variable and a relatively low
number of mobility outcomes. Also, the mechanism by which muscle energetics impacts
mobility remains unclear, and it seems likely that other characteristics of muscle
energetics, such as non-oxidative ATP flux, may be of importance as well. A more
comprehensive framework of the relationship between muscle energetics and mobilityrelated function, such as the one proposed in Fig. 22, would be beneficial for
understanding and combating aging and physical inactivity-related issues. One major
obstacle to this is the restriction of 31P-MRS measurement to the bore of a magnetic
resonance scanner. If in vivo muscle energetics could be assessed during mobility tasks, it
would be much easier to uncover a potential energetic mechanism by which performance
in those task may be impaired. While technology is far from allowing this type of
analysis, measurement of whole-body energetics may provide an alternative mechanistic
avenue. Although a correlation between muscle and whole-body energetic characteristics
cannot prove causality, it would show that the changes in whole-body energetics (that
have been associated with decreases mobility-related function), can be partially explained
through decrement in muscle energetic function. Such a relationship would suggest that
improving muscle energetic capacity - perhaps through isolated single joint exercises could be an effective strategy for improving mobility-related function.

41

Figure 22. The proposed framework for physiological interactions that lead
to decreases in mobility-related function. Adapted from (24).
Proposed Solution
Characteristics of whole-body energetics have long been linked to exercise
performance (26, 52, 104), and more recently measures of mobility-related function (4, 9,
15, 98, 99). Indirect calorimetry measurements of whole-body energetics have also been
linked to those of in vivo muscle energetics (2, 63, 111) and their relationship has even
been evaluated simultaneously on multiple occasions (19, 21, 73, 82, 93, 94), albeit only
in highly constrained settings. Based on these observations whole-body energetics could
potentially act as an intermediary point between muscle energetics and mobility-related
function (Fig. 22).

The Advantages of Whole-body Energetic Measures
Due to its relatively low cost and accessibility, non-invasive nature, and
physiological relevance, indirect calorimetry has become a popular means of bioenergetic
study. Indirect calorimetry measures have long been performed on athletes where they
have been used as indices of performance or fitness (33), or a tool for training (101).
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These approaches have also been applied in the world of medicine in the areas of diabetes
(13), cardiorespiratory fitness (75), pediatric care (83), nutrition (45), and aging (61, 80,
88). From such studies we know that in older adults the energy cost of daily activities and
exercise are relatively higher (61, 107), exercise capacity is lower (107), and VO2
recovery kinetics are slowed (88).
Recently, a growing number of studies have used indirect calorimetry to evaluate
the effects of aging components of mobility-related function. Many of these studies have
focused on the impact of the increased energetic cost of walking and decreased aerobic
capacity (VO2 max) observed in older adults (9, 92, 98, 99). Their findings suggest that
the slowing of gait speed that occurs with walking may be a compensatory action for the
increased energetic cost, such that older adults walk slower to maintain an energy
expenditure during transport similar to that of young healthy individuals (9, 92, 98, 99).
An increased energetic cost of walking has also been shown to be associated with higher
rates of perceived fatigability and rating of perceived exertion cross-sectionally (9, 92),
and more recently longitudinally (98). It has also been proposed that the difference
between walking oxygen consumption and maximal oxygen consumption, representing
the “aerobic reserve”, has important consequences for mobility, such that older adults that
with a smaller aerobic reserve may be more limited during mobility task. Likewise, older
adults that require a higher percentage of their peak oxygen consumption to walk have
been shown to have reduced preferred gait speed and increased fatigability (92, 98).
Other metrics, such as the kinetics of O2 uptake have received less attention, but
may be equally as important. In 2003, Alexander et al. (4) suggested that, although
aerobic capacity is often used as an indicator of function in older adults that submaximal
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measures (O2 kinetics) may be a more practical measure of aerobic function because it
does not require maximal effort testing; which can be confounded by participant
motivation or other pathological limitations. In testing this, it was shown that when
compared to unimpaired older adults (VO2 peak >18 ml∙kg-1∙min-1), impaired older adults
(VO2 peak <18 ml∙kg-1∙min-1) had over twice the time constant for O2 deficit and trended
towards (p=.09) a 43% higher time constant for EPOC (Fig. 23 A-B.). It was also
demonstrated that O2 kinetics were as strong or stronger predictors of functional
performance during a variety of mobility-related tasks (Fig. 23 C.) (4), and lowfrequency fatigue (104).
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Figure 23. A-B) Oxygen deficit and EPOC in
unimpaired and impaired older women, respectively,
C) Pearson’s correlations between aerobic
measurements and mobility test performance. (4)
A limitation of all of these studies has been the measurement of aerobic metrics
during brief periods of walking or running in a laboratory setting. For example,
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Alexander et al. measured O2 kinetics in response to a very slow (1 mph) 6 min treadmill
walk, with only 3 min of collection pre and post, and the other studies measured only the
total cost of walking and VO2 peak or max. Although walking is a major component of
mobility, the whole-body energetic responses during the mobility task themselves could
be beneficial for assessing mobility-related functions during daily living. Also, longer
periods of measurement may be useful as metrics such as EPOC have been shown to last
as long as 14 hr in response to more intense exercise. In 2013, Buchowski et al. (15)
measured energy expenditure in response to eight different physical tasks, for three hours
in a whole room calorimeter. This was one of few studies to examine the effects of
energy expenditure during a task on perceived fatigability and performance fatigability
(measured through accelerometry), and they found both were significantly related to total
energy expenditure during the task that required around 3.5 METs (15). However, they
only considered the amplitude of energy expenditure, and based on Alexander’s research
it is possible that further analysis of O2 kinetic measurements may have uncovered
associations between energetics and fatigability during lower-intensity tasks as well. This
is an approach that our lab could potentially use in the future.
Together these studies demonstrate the efficacy of indirect calorimetric
measurements for the assessment of mobility-related function. It should be clear that
linking these lines of energetic research to in vivo muscle energetic research could be
greatly beneficial to both sides and may provide a mechanistic pathway by which altered
muscle energetics impact mobility-related function. As will be explained in the following
section, much of the groundwork to establish this connection has already been completed.

46

While inferences based on this work could currently be made, it is the aim of this study to
validate these assumptions.
The Relationship between Muscle and Whole-body Energetics
Basic physiology and logic dictate that muscle energetics are related to wholebody energetics as follows; 1) indirect calorimetry measures the sum of energy
expenditure (O2 consumption and CO2 production) from all of the body’s cells, 2) muscle
accounts for ~20-30% of whole-body energy expenditure during rest, and up to ~90%
during exercise depending on intensity (110), 3) the way muscles use energy (muscle
energetics) should, therefore, have an impact on whole-body energetics with an
amplitude corresponding to the activity being performed. The precise interactions of this
relationship, however, are not implicit and have thus been subject to investigation.
Chilibeck et al. in 1998 and Rossiter et al. in 2002 (21, 93), both approached this problem
by simultaneous measurement of phosphorous and O2 kinetics (i.e., rates of change).
Both groups used isolated exercise (plantar flexion and knee extension) inside a magnetic
resonance scanner and found similar time constants and kinetics between measurements.
Rossiter et al. also found that during intense exercise the VO2 slow component was
reflected in PCr consumption (Fig. 24). Other research groups have used this connection
to investigate topics such as energy cost, energy efficiency, and quantification of aerobic
and anaerobic contributions (19, 73, 82).
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Figure 24. The simultaneous response of VO2 and PCr kinetics to
different intensity constant rate exercise. The graphs on the left are from
the onset of exercise and the graphs on the right are from the cessation. Filled
circles represent heavy exercise and open circles represent moderate (93).
These studies are limited to exercise in the confines of a magnetic resonance
scanner. Thus, other researchers have used non-simultaneous measures to investigate the
importance of muscle energetics in relation to more practical whole-body measures. For
example, Zwaard et al. (111), showed that although VO2 max is likely limited by O2
delivery and not mitochondrial respiration, that muscle fiber oxidative capacity (in vitro)
is highly correlated (r2 = .81-.89) with VO2 max in diseased (CHF), healthy, and
endurance-trained participants. Similar observations found that muscle mitochondrial
capacity in the gastrocnemius assessed by near-infrared spectroscopy was associated with
VO2 peak (R2 = .57) and EPOC duration (R2 = .34) (63), and that age-related decline in
muscle oxidative capacity in the vastus lateralis measured by 31P-MRS correlated with a
decline in VO2 peak (R2 = .541) as well (3).
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While these measures add a level of practicality to interpreting the whole-body
effects of alterations in muscle energetics, they do not provide enough support for the
comprehensive analysis of how such alterations might affect mobility-related function in
everyday life that is the goal of this lab. For this reason, this study attempted to elucidate
a strong relationship, if one exists, between dynamic measures of both muscle and wholebody energetic characteristics.
Summary
In summary, 1) the methods used to evaluate muscle energetics and whole-body
energetics are valid and have strong physiological bases; 2) there is reason to believe that
characteristics of both are inherently connected, especially in regards to exercise; 3)
characteristics observed at both levels have been previously associated with indices of
mobility-related function, but more thoroughly and directly at the whole-body level; 4)
analysis of kinetic attributes at both muscle and whole-body levels and not just total or
maximal energy consumption could further the understanding of this connection, as well
as the relationship to mobility-related function; and 5) whole-body energetics could
potentially act as an intermediary point between muscle energetics and mobility-related
function, which with further research could advance the field by providing a mechanism
that can be used to evaluate and combat decline in mobility-related function.
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CHAPTER 3
METHODS
Study Overview
This thesis study was completed on a subset of data from a larger multi-lab
project. As such, portions of the larger project that are not directly relevant to this thesis
are not included here but can be provided upon request. The purpose of this project was
to evaluate the connection between muscle (vastus lateralis) and whole-body energetics.
Muscle energetics were analyzed using MRS in response to two separate knee-extensor
contraction protocols and whole-body energetics were analyzed using indirect
calorimetry in response to a treadmill walk designed to mimic what an individual might
encounter during a typical day.
All participants completed 4 total visits at the Institute for Applied Life Sciences
inside either the Center for Human Health and Performance (CH2P) or the Human
Magnetic Resonance Center (hMRC). The first visit included consenting (informed
consent can be found in Appendix A), anthropometric measures, a dual-energy X-ray
absorptiometry (DXA) scan, and a 30-min treadmill walk (30MTW) monitored by a
metabolic cart. The following three visits consisted of two stays in a whole-room
calorimeter (24-h visits), and one 3-h visit (MR Visit). The 24-h visits consisted of an
overnight stay including three meals, structured activities of daily living (ADL’s), and the
30MTW, all interspersed with free-time. The MR visit included magnetic resonance
spectroscopy (MRS) measures, both at rest and during knee extension exercise, followed
by a graded maximal oxygen consumption treadmill test (VO2 peak test). For all visits,
participants were asked to abstain from alcohol, tobacco, and exercise for the previous 24
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hours, and caffeine the morning of. All visits were completed within 30 days. An
overview of the visits and measurements is shown in Fig. 25.

Figure 25. Study Visit Overview. DXA, dual-x-ray absorptiometry; 30MTW,
30-min treadmill walk; RC, room calorimeter; MR, magnetic resonance; MRS,
magnetic resonance spectroscopy; VO2, volume of oxygen consumed.

Participants
This study has been approved by the University of Massachusetts Amherst
institutional review board. Eight young (25-40 yrs.), healthy males were recruited for this
study. All participants were relatively weight stable (∆ weight < ± 5lbs for two months
prior) and ranged from sedentary to recreationally active. Participants were free of any
musculoskeletal injury, and acute or chronic illness that may affect their neuromuscular
or metabolic function. Additionally, participants were screened for medications that have
the potential to impact study results (screening form can be found in Appendix B).
Dietary restrictions and preferences were also be recorded to ensure the safety of and
adherence to the provided meals.
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Meals
For all visits, participants were fed a standardized 400 kcal meal bar (PRO Bar,
Park City, UT) at 11:30 am for lunch (for the MR visit the bar was given to the
participant prior). The macronutrient distribution was 43g of carbohydrate, 22g of fat,
and 11g of protein, and was chosen to be both satiating and relatively low calorie. The
key measurements of each visit (indirect calorimetry and MRS) occured roughly 2.5-3.5
hrs after lunch (commencing at ~2:00 pm). This standard meal and timing helped to
control for the thermic effect of food on energy expenditure as well as other meal-based
stimuli and diurnal variations, however, some inter-participant variation likely remained.
Descriptive Data
Physical Activity Monitoring
Following Visit 1, participants were asked to wear a GT3x+ accelerometer
(ActiGraph, Pensacola, FL) on their dominant hip for 7 days, and fill out an
accompanying physical activity log to classify their habitual, free-living physical activity.
This is a standard practice in our lab, and these data were used to identify free-living
physical activity levels and determine their potential effect on the results. The participant
was instructed to wear the accelerometer on their right hip. A minimum of 4 days with 10
hours of wear time per day was required to be included in the analysis. ActiLife v6.13
software (ActiGraph, Pensacola, FL) was used to calculate average daily activity counts
as well as minutes spent in moderate-to-vigorous physical activity.
During each 24-hour visit participants tracked their step count using the screen on
a GT9X accelerometer (ActiGraph, Pensacola, FL) and were asked to reach a step count
goal of 1200 steps before 12:00 pm in an attempt to avoid complete inactivity.
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Anthropometrics and DXA Scan
Height, weight, and femur length (greater trochanter to lateral condyle) were
measured and recorded for all participants. All measures were completed twice and
averaged. Next, a full-body DXA scan was obtained by a certified technician on a Lunar
iDXA (GE Lunar, Madison, Wisconsin, USA), to quantify body composition. These data
were used for normalization and anthropometric comparison of participants, as well as
for choosing the correct height settings on the magnet ergometer. Primary outcomes of
these measurements included weight, body mass index (BMI), lean body mass (LBM),
and fat mass.
Whole-body Metabolic Measures
Treadmill Walk
The 30MTW protocol (37, 43) was performed at 2:00 pm during visit 1, and both
24-h visits. The treadmill speed (incline = 0%) was increased over the first 30 s until 1.3
m∙s-1 is reached. This speed was set to be achievable by most populations and was based
on the average overground walking speed (1.37 m∙s-1) completed by 17 older women in a
previous study in our lab (37). At minutes 7, 17, and 27, grade was increased to 3% for 1
min to provide a slight challenge and to simulate a hill that the participant might
encounter in everyday life. After 1 min, the grade was returned to level. Immediately
before the 30MTW, participant gas exchange rates was measured during 20 min of quiet
sitting followed by 10 min of quiet standing during which time a television show was
played. Following the walk, the participant were required to remain seated and passive
for a 1-hr recovery period at visit 1 and a 2-hr recovery period at the 24-h visits, during
which time a television show was played.
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During the first visit, metabolic response to the 30MTW were monitored with a
Parvo Medics’ TrueOne® 2400 (Salt Lake City, UT) metabolic cart, which was
calibrated according to manufacturer recommendations prior to the participant’s arrival.
Data was sampled breath by breath and recorded in ~5-s averages. During postprocessing, data was inspected for errors and smoothed using a 3-sample (~15 s) centered
moving average.
During the 24-h visits, metabolic response to the 30MTW was monitored using a
custom-built full room calorimeter (MEI Research, Enida, MN) as part of a longer 24 hr
stay. The calorimeter (4.1 by 3.3 m) is configured for long-duration stays during which
individuals can receive meals or medications through pass-through ports. It houses a
toilet, sink, bed, desk, TV, treadmill (Valliant 2, Lode, Groningen Netherlands), and a
two-camera observational video system. The calorimeter was calibrated using zero (0%
CO2, 21% O2) and span (1% CO2 and 20% O2) gases before the participants arrive. A
walkie-talkie was provided for communication while inside the calorimeter. Data was
sampled every 15s and post-processed using a 6-min centered derivative.
These data were used to determine the energetic response to and recovery from a
light intensity free-living task. Data from the first visit allowed for oxygen kinetic
analyses of higher temporal resolution than can be recorded from the room calorimeter.
Data from the 24-h visits allowed for analysis of a longer recovery period than would be
comfortable with the metabolic cart.
VO2 Peak Measures.
Following the MR measures, the participant was removed from the scanner and
given time to use the restroom, then was taken upstairs to the CH2P for measurement of
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peak oxygen consumption (VO2 peak). Graded exercise tests have long been used to
determine the maximal amount of oxygen that can be consumed for aerobic (oxidative)
energy production, often referred to as VO2 max. In this study, we chose to use the term
VO2 peak as opposed to VO2 max due to the inherent difficulties in determining whether
or not an individual truly reaches their physiological limit. Our use of the term peak
denotes that we accept that our values may not represent true maximal values, but simply
the peak values observed on that day. Participants completed a self-paced ~5-min warmup on a treadmill. A TrueOne® 2400 metabolic cart was used to measure gas exchange
and respiration rate during the VO2 peak test. Data was sampled breath by breath and
recorded in ~5-s averages. The test followed the BSU/Bruce Ramp treadmill protocol as
described by Kaminsky and Whaley (53). This protocol is designed to be well suited for a
wide range of populations through its use of a gradual ramp in intensity allowing for long
walking periods and small transitions between stages. The test begins with a .76 m∙s-1 flat
walk and gradually increases in speed or incline. Heart rate, oxygen consumption, and
RPE were monitored throughout the test. Termination criteria consisted of any one of the
following, volitional fatigue, a plateau in oxygen uptake at several consecutive
workloads, safety concerns, or equipment malfunction. During post-processing, data was
inspected for errors and smoothed using a 6-sample (~30 s) centered moving average.
The highest 30 s average was taken as the VO2 peak, which was the primary outcome of
this measurement. A table detailing the test stages can be found in Appendix C.
Muscle Bioenergetics
Magnetic Resonance Measures
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Upon arriving at the hMRC, participants reviewed the MR Safety Form with the
MR Technician, and all metal objects were removed. They were escorted into the scanner
room and positioned on their back on the bed of the 3 Tesla whole-body MR system
(Siemens, Erlangen, Germany). Their dominant leg was be strapped into the custom-built
leg exercise apparatus, which is similar to a knee extension machine one might use at a
gym. The leg was strapped to the apparatus just above the ankle and above the knee using
Velcro straps. Inelastic straps were secured over the participant’s hips to prevent
unwanted movement during the muscle contractions. A circular 10-cm, dual-tuned
(phosphorus and proton) coil was secured over the belly of the vastus lateralis muscle
using an elastic bandage and Velcro straps. After the participants were secured to the legexercise apparatus, their thigh was positioned in the isocenter of the scanner and the
magnet was shimmed. After the magnet was shimmed to an acceptable level of
homogeneity, resting proton spectra was obtained for the measurement of cytosolic
acetyl-carnitine. These measurements will be used in the analysis of the muscle energetic
response to exercise in a tangential study. A visual outline of the magnetic resonance
procedures can be seen in Fig. 26.

Figure 26: Magnetic Resonance Spectroscopy Protocol
Muscle Power Measures
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Participants completed 2 practice submaximal isometric contractions, followed by 3
maximal voluntary isometric contractions (MVIC), each lasting 3-4 s, to establish the
workload for the ramp contraction protocol. One minute of rest was given between each
set of contractions. Participants were then be familiarized with isokinetic contractions (1
contraction every 2 s at 120 s-1) by performing 2 sets of 3 contractions. During all knee
extensor protocols, participants had visual feedback showing the torque they produced as
well as their target torque and the timing of contractions.
Oxidative Capacity
The oxidative capacity protocol consisted of 90 s of rest, 24 s of maximal
isokinetic contractions (1 contraction every 2 s at 120 s-1), and 10 minutes of recovery.
Phosphorus spectra was collected at 2 s resolution for the entire protocol. During postprocessing, the first 15 spectra (30 s) were discarded to avoid saturation issues. The
remaining resting spectra were then averaged together into one 60 s spectrum. During the
24 s of exercise and the first 20 s of recovery spectra were averaged to 4-s resolution, the
following 280 s of recovery to 8-s, and the last 300 s to 30-s. These data were used to
determine the maximal aerobic energy production in the muscle. The primary outcome
for this measurement was muscle oxidative capacity (measured as a rate constant, kPCr, s1)

.

Ramp Contraction Protocol
Following the oxidative capacity measures, participants performed a ramp
contraction protocol consisting of 90 s of rest, four 2-min stages of isotonic knee
extensions (1 contraction performed every 2 s), and 10 min of recovery. Resistance for
the stages were set at 6, 9, 12, and 15% of MVIC and occured in that order. Phosphorus
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spectra were collected at 2 s resolution for the first 12 min of the protocol. Two and a half
minutes into recovery, phosphorus scans ceased and ~5.5 min of proton shimming and
scanning was performed (for purposes outside the scope of this project), following which
two and a half more minutes of phosphorus were collect at 2 s resolution. In this way, we
collected a full ~10 min of phosphorus recovery, with a gap in the middle that can be
accounted for through a monoexponential fit. During post-processing, the first 15 spectra
(30 s) were discarded to avoid saturation issues. The remaining resting spectra were then
averaged together into one 60 s spectrum. During the 480 s of exercise spectra were
averaged to 10-s resolution, the first 20 s of recovery to 4-s, the following 128 s to 8-s,
and the last 150 s collected after the proton scanning to 30-s with the first 15 spectra
discarded. These data were used to evaluate the energetic characteristics of contracting
muscle at various intensities. Primary outcomes included the amplitude of ∆PCr from the
first intensity stage (PCr mM).
Kinetic Analysis
Kinetic analysis of both oxygen consumption and PCr responses was performed
using the MATLAB 2020a curve fitting toolbox (The MathWorks Inc., Natick,
Massachusetts). Oxygen deficit was fit from the onset of the 30MTW to just before the
first challenge period at 7 min using the following monoexponential equation.
VO2(t) = (mean VO2 Last Minute of Standing) + a ∙ (1 - e (-(t-d)/tc))
Eq. 8
The EPOC was fit from the time the participant has sat down at the end of the
30MTW through 1 hour of recovery using this similar monoexponential equation.
VO2(t) = (mean VO2 Last Minute of 30MTW) – a ∙ (1- e (-(t-d)/tc))
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Eq. 9
The variable a represents the amplitude of change in oxygen consumption, t represents
time, d represents the time delay between the change in physical work and the oxygen
response, and tc is the time constant representing the amount of time in seconds it takes
for the amplitude to change by 63%. All variables were constrained to a minimum value
of 0.
The PCr recovery data was fit from the end of the 24-s oxidative capacity protocol
to 10 minutes of recovery using the following monoexponential equation.
PCr(t) = Y0 + a ∙ (1- e (-k ∙ t))
Eq. 10
The variable Y0 is the estimated PCr concentration during the last 4 s of exercise, a
represents the amplitude of change in PCr, t represents time, and k is the rate constant.
All variables were constrained to a minimum value of 0.
The PCr data from the first stage of the ramp was fit from the onset of
contractions to the beginning of the second stage (2 min) using the same equation, except
the variable Y0 is now the estimated PCr concentration at rest and is subtracted from.
PCr(t) = Y0 - a ∙ (1- e (-k ∙ t))
Eq. 11
Statistics
Data was analyzed as a single group. Descriptive data is reported as mean values
with standard deviation and ranges. Due to the low number of participants correlations
were assessed with the non-parametric Spearman’s rank correlation coefficient test (rs) in
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MATLAB 2020a (The MathWorks Inc., Natick, Massachusetts) using the “corrplot”
function.
Aim 1: Evaluate the relationships between ∆PCr in muscle and the O2 deficit
during the 30MTW.
To test Aim 1, a Spearman’s rank correlation test was performed to determine the
association between the independent variable (∆PCr in the VL during the knee extensor
contraction protocol; amplitude (a) mM) and the dependent variable (O2 deficit from the
30MTW, kdeficit).
Aim 2: Evaluate the relationships between muscle oxidative capacity and: EPOC
and RER in response to activities of daily living, and VO2 peak from a graded exercise
test.
To test Aim 2, several Spearman’s rank correlation tests were performed to
determine the association between the independent variable (muscle oxidative capacity
from the isokinetic protocol; kPCr, s-1) and the dependent variables (EPOC and substrate
use from the 30MTW; kEPOC and RER, and VO2 peak relative to total and lean body mass
from the graded treadmill test; O2 mL∙kg-1∙min-1).
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CHAPTER 4
RESULTS
Participant Characteristics
Male participants aged 25-40 years who were not actively training for or
participating in organized sports were recruited for this study. Eight participants were
enrolled and completed all four visits. Upon enrollment, each participant was assigned an
arbitrary number between 1 and 11 to serve as a de-identified participant code (denoted
here as pt#). All participants self-reported being weight stable (< ±5lbs for 2 months), and
free from chronic disease and injury. Group data provided in Table 2.
Table 2. Participant characteristics
Age (years)
28.4 ± 3.5
(25, 35)
Height (cm)
179.6 ± 9.3
(164, 189)
Weight (kg)
88.7 ± 15.5
(65.5, 105.3)
Lean Body Mass (kg)
64.9 ± 11.6
(47.4, 84.8)
-2
BMI (kg∙m )
27.2 ± 2.7
(22.6, 30.2)
Body Fat (%)
20.3 ± 7.1
(13.8, 33)
-1
MVPA (min∙d )
33 ± 13.8
(6, 48)
PA (counts∙d-1000)
400 ± 115
(244, 600)
MVIC (Nm)
283 ± 67
(172, 370)
Data are mean ± SD and (range); BMI, body mass index; MVIC,
maximal voluntary isometric contraction; MVPA, moderate- to vigorousintensity physical activity; PA, physical activity

Whole-body Metabolic Responses to 30MTW
Room Calorimeter Measurements
Due to the low temporal resolution of the whole-room calorimeter data, a standard
analysis of oxygen kinetics was not feasible. Further evaluation will be required to
determine if meaningful kinetic measures can be extracted from these data. For this
reason, we report whole-body metabolic data collected using the metabolic cart.
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Treadmill Walk
All participants completed the 30MTW protocol at the prescribed speed of 1.3
m∙s-1. During seated rest (pre and post-walk), all participants watched documentary-style
television shows. The first 4 participants were allowed ad libitum access to their phones.
Phone use was not allowed following the 4th participant (pt7) due to unexpected increases
in VO2 observed while that participant was holding the phone high in front of their face
for an extended period of time. Additionally, metabolic cart data for one participant (pt4)
was excluded from analysis due to unusually large oscillations in the VO2 signal that
made it unsuitable for analysis. It has yet to be determined whether this problem was due
to an equipment artifact or physiologic phenomenon.
Metabolic Variables during the 30MTW
Analysis of the metabolic cart data from the 30MTW walk protocol showed that
oxygen consumption increased from sitting to walking by ~3-4 fold for all participants
and steady-state was reached before the first challenge period 7 min into the walk.
Oxygen consumption averages from minutes: 10-19 of sitting pre-walk (VO2 Sitting), 5-9
of standing pre-walk (VO2 Standing), and 7-30 of walking (VO2 Walking) were taken to
be representative of those periods while avoiding influence from the transitions between
them. Representative VO2 and RER responses are shown in Fig. 27. Mean treadmill walk
metabolic variables are presented in Table 3.
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Figure 27: Representative plot of metabolic data from 30MTW. Data are
from a single participant (pt9) during the 30-min treadmill walk; VO2, volume
of oxygen consumption; RER, respiratory exchange ratio.
Table 3. Treadmill walk metabolic variables
Participant
VO2 Sitting
VO2 Standing
-1
-1
(mL∙kg ∙min ) (mL∙kg-1∙min-1)
pt1
3.4
3.6
pt2
4.3
5.4
pt4
pt6
3.1
3.5
pt7
1.9
2.7
pt9
3.7
3.5
pt10
3.1
3.3
pt11
3.4
3.8
Mean ± SD
3.2 ± 0.7
3.7 ± 0.8
VO2, volume of oxygen consumption

Respiratory Exchange Ratio
63

VO2 Walking
(mL∙kg-1∙min-1)
13.7
12.5
11.1
10.2
10.8
12.9
12.9
12 ± 1.3

The RER response to the 30MTW, was calculated as averages across different
time periods. Representing RER as an average, as opposed to picking a single time point
(minimum, maximum, or final), limits the impact of noise in the data. As shown in Fig.
27, RER during the 30MTW took longer to reach a steady than VO2, a finding consistent
across participants. For this reason, averages were calculated for the entire oxygen
consumption steady state (minutes 7-30; RER L23) and the last minute (minute 29-30;
RER L1) of the 30MTW. Additionally, an average of the last 5 min was calculated
(minutes 25-30; RER L5), to account for fluctuations that may occur during the last
minute due to the final challenge period (minute 27-28) or noise that if not sufficiently
filtered by the small sample of RER L1 (12 data points). The RERs from these three time
periods (L23, L5 and L1) did not statistically differ by means of one way ANOVA (p=
0.47) or Kruskal-Wallis test (p = 0.43). Individual RER data can be found in Fig. 28 and
Table 4.
1
0.95
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0.9
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0.75
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p11
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Figure 28. Individual RER values from the 30MTW. 30MTW, 30min treadmill walk; RER, respiratory exchange ratio; L23, average of
the last 23 min of walk; L5 average of the last 5 min of walk; L1 average
of the last 1 min of walk.
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Table 4. Individual RER values from the 30MTW
Participant
RER L23
RER L5
RER L1
pt1
0.89
0.89
0.91
pt2
0.83
0.84
0.85
pt4
pt6
0.83
0.80
0.83
pt7
0.86
0.86
0.90
pt9
0.85
0.84
0.85
pt10
0.90
0.87
0.89
pt11
0.87
0.88
0.90
Mean ± SD
0.86 ± 0.03 0.85 ± 0.03 0.87 ± 0.03
30MTW, 30-min treadmill walk; RER, respiratory
exchange ratio; L23, average of the last 23 min of walk;
L5 average of the last 5 min of walk; L1 average of the last
1 min of walk; * denotes significantly different means

On- and Off- Kinetics for Metabolic Variables
To determine the time constants for the oxygen deficit (on-kinetics) and EPOC
(off-kinetics), monoexponential equations (Eq. 8 and 9) were fit to each participant’s
oxygen consumption data during the 30MTW. For two participants (pt1 and pt2) the time
at which the walk ended and the time at which the participants began seated rest was not
recorded. In these two cases, EPOC was defined as starting from the last VO2 value at or
above the steady-state mean, and the mean VO2 Last Minute of 30MTW was calculated as
the average of the minute before that same point. In addition, the minimum time delay (d)
for these two participants was constrained to -5 s (as opposed to 0) to allow the fit to
account for a possible error in identifying the end of the 30MTW of up to one data point.
The fit of the EPOC data for participant 7 was adjusted for the effect of phone use
mentioned above (see Appendix D for details). Figure 29 shows representative fits of the
VO2 data illustrating the oxygen deficit and EPOC analyses. The time constants from
these fits can be found in Fig. 30, as well as Tables 5 and 6.
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Figure 29. Representative fits of data showing (A) oxygen deficit and (B)
EPOC. Data are from a single participant (pt9). Time constants here are 37 s
for oxygen deficit and 69 s for EPOC. VO2, volume of oxygen consumption.
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Figure 30. Individual oxygen deficit and EPOC time constants from
the 30MTW. EPOC, excess post-exercise oxygen consumption;
30MTW, 30-min treadmill walk.
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Table 5. Oxygen deficit variables
Time constant
(95% CB)
Amplitude
r2
(s)
(mL∙kg-1∙min-1)
pt1
38
(29, 47)
0.78
10.2
pt2
25
(5, 45)
0.24
6.7
pt4
pt6
19
(11, 26)
0.37
7.4
pt7
23
(17, 30)
0.67
6.9
pt9
37
(28, 46)
0.64
7.8
pt10
27
(19, 35)
0.61
8.8
pt11
27
(19, 35)
0.70
7.8
Mean ± SD
28 ± 7
0.57 ± 0.20
7.9 ± 1.2
SD, standard deviation; 95% CB, 95% confidence bounds for the time constant
Participant

Time delay
(s)
1.0
1.2
0
0
0
0
1.3
0.5 ± 0.6

Table 6. EPOC variables
Time constant
(95% CB)
Amplitude
Time delay
r2
(s)
(mL∙kg-1∙min-1)
(s)
pt1
57
(53, 61)
0.63
10.3
-5
pt2
43
(37, 49)
0.27
8.6
-5
pt4
pt6
47
(36, 58)
0.40
7.9
0
pt7
78
(68, 87)
0.53
8.6
0
pt9
69
(62, 76)
0.56
7.8
0
pt10
65
(61, 70)
0.65
9.1
0
pt11
53
(50, 56)
0.74
9.6
0
Mean ± SD
59 ± 13
0.54 ± 0.16
8.8 ± 0.9
-1.4 ± 2.4
EPOC, excess post-exercise oxygen consumption; SD, standard deviation; 95% CB, 95%
confidence bounds for the time constant
Participant

VO2 Peak
The VO2 peak tests ranged from 11 to 16 min in duration, and all tests were
terminated upon volitional fatigue. For two participants (pt2 and pt6) heart rate data was
not recorded due to equipment failure. To further evaluate how muscle energetics may
play a role in this relationship VO2 peak is reported here normalized to both total mass
(mL∙kg-1∙min-1) and lean mass (mL∙kg lean-1∙min-1). Representative changes in oxygen
consumption and RER can be found in Fig. 31. Individual VO2 peak data can be found in
Fig. 32 and Table 7.
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VO2
Peak

Figure 31. Representative data from the ramp treadmill protocol. Data
are from a single participant (pt9). VO2, volume of oxygen consumption;
RER, respiratory exchange ratio.
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Figure 32. Individual VO2 peak values from the ramp treadmill
protocol. VO2, volume of oxygen consumption
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Table 7. VO2 peak values from the ramp treadmill protocol
Participant

VO2 Peak
(mL∙kg-1∙min-1)
38.0
52.6
44.1
38.4
38.8
47.2
36.9
47.1
42.9 ± 5.7

VO2 peak lean
(mL∙kg-1 lean∙min-1)
52.5
72.8
59.2
60.4
51.9
61.1
51.6
57.8
58.4 ± 7.0

Max Max HR Max RPE
RER
pt1
1.34
201
10
pt2
1.10
10
pt4
1.23
190
10
pt6
1.14
10
pt7
1.27
202
10
pt9
1.22
197
9
pt10
1.25
200
10
pt11
1.20
179
10
Mean ± SD
1.20 ± 195 ± 9
9.9 ± 0.4
0.1
VO2, volume of oxygen consumption relative to total mass; Max RER, maximal
respiratory exchange ratio; Max HR, maximal heart rate; Max RPE, maximal rating
of perceived exertion; SD, standard deviation.

Muscle Bioenergetic Variables
Oxidative Capacity
The 24-s isokinetic protocol led to an average PCr recovery of 14.1 ± 3.8 mM
(Table 8). No participant’s muscle pH dropped below 6.8 during any part of the protocol,
suggesting that PCr replenishment was not hindered in any case by H+ accumulation.
Individual fit variables are shown in Table 8 and a sample PCr fit for a single participant
can be seen in Fig. 30.

Figure 33: Representative monoexponential fit of PCr recovery data
from the oxidative capacity protocol. Data are from a single participant
(pt9) with a kPCr of 0.034 s-1. PCr, phosphocreatine.
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Figure 34. Individual oxidative capacity rate constants.
kPCr (s-1), rate constant of PCr recovery;
Table 8. Oxidative capacity individual fit variables
Rate constant
(95% CB)
r2
y-intercept Amplitude
-1
(mM)
(mM)
(kPCr, s )
pt1
0.029
(0.026, 0.032)
0.98
25.0
13.4
pt2
0.039
(0.035, 0.044)
0.97
20.1
18.7
pt4
0.023
(0.025, 0.028)
0.99
25.1
14.6
pt6
0.045
(0.036, 0.054)
0.93
30.2
6.2
pt7
0.019
(0.017, 0.020)
0.99
25.0
12.9
pt9
0.034
(0.031, 0.036)
0.99
23.8
16.0
pt10
0.027
(0.025, 0.030)
0.98
21.4
17.9
pt11
0.026
(0.024, 0.028)
0.99
24.4
13.3
Mean ± SD 0.030 ± 0.009
0.98 ± 0.02 24.3 ± 3.0
14.1 ± 3.8
SD, standard deviation; 95% CB, 95% confidence bounds for the rate constant; kPCr, s1, rate constant of PCr recovery.
Participant

Non-Oxidative ATP Production
Data from the first 2-min stage were used to calculate the amplitude of ∆PCr for each
participant, thereby reflecting the contribution of ATP production from the (nonoxidative) creatine kinase reaction. The target relative intensity of this stage was 6% of
MVIC. The mean MVIC was 282 ± 67 Nm and the mean target load was 17 ± 4 Nm. The
measured mean load was 21.9 ± 5.2 Nm, representing 7.8 ± 0.6 % MVIC. Individual fit
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variables are presented in Table 9 and an example PCr fit for a single participant is shown

PCr (mM)

in Fig. 31.

Time (s)
Figure 35. Representative fit of changes in PCr during stage 1 of ramp
protocol. Data are from a single participant (pt9) with a ∆PCr of 7.4 mM. PCr,
phosphocreatine.
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Figure 36. Individual ∆PCr during stage 1 of ramp protocol. PCr,
phosphocreatine.
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Table 9. Variables from fit of ∆PCr
Rate constant
(95% CB)
r2
y-intercept Amplitude
-1
(Y0)
(a)
(kPCr, s )
pt1
0.034
(0.027, 0.041)
0.99
38.4
11
pt2
0.072
(0.037, 0.11)
0.92
37.7
4.7
pt4
0.017
(0.012, 0.023)
0.99
38.4
10.7
pt6
0.093
(0.042, 0.14)
0.91
36.4
4.8
pt7
0.020
(0.016, 0.025)
0.99
38.4
8.6
pt9
0.021
(0.014, 0.029)
0.97
38.7
7.4
pt10
0.023
(0.013, 0.032)
0.97
36.9
7.5
pt11
0.024
(0.017, 0.031)
0.98
36.9
6.9
Mean ± SD 0.038 ± 0.028
0.97 ± 0.03
37.7 ± 0.9
7.7 ± 2.4
SD, standard deviation; 95% CB, 95% confidence bounds for the rate constant; kPCr s-1,
rate constant of PCr depletion.
Participant

Associations between Single Muscle and Whole-body Energetics
To evaluate these relationships Spearman rank correlation coefficients were
calculated. The coefficient output rs is similar to the r variable from a Pearson correlation
and represents the strength of association. A strong Spearman correlation suggest a
monotonic (directional; up or down) relationship, but not necessarily a linear one. The
linearity of relationships was inferred through visual interpretation of the association
plots. Probability values (p-values) were calculated for all correlations as well; however,
due to the low sample size and this being an exploratory analysis, we did not set an alpha
level for significance. The magnitude of ∆PCr showed a positive linear relationship with
oxygen deficit (Fig. 37). Muscle oxidative capacity showed a negative linear relationship
with EPOC, as shown in (Fig. 38). Muscle oxidative capacity showed a negative linear
association with the mean RER from the entire steady-state (RER L23), the last 5 min
(RER L5), and the last minute (RER L1) (Fig. 39). Muscle oxidative capacity had a
positive linear association with VO2 peak relative to lean mass, but no relationship to
VO2 peak relative to total mass as shown in (Fig. 40). The correlation coefficients of the
association between both independent variables and all of the dependent variables
(corresponding to both aims) are reported in Table 10.
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Figure 37. Association between oxygen deficit and ∆PCr. PCr,
phosphocreatine; rs, Spearman’s rank correlation coefficient
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Figure 38. Association between EPOC and muscle oxidative
capacity. EPOC, excess post-exercise oxygen consumption; PCr,
phosphocreatine; kPCr s-1, rate constant of PCr recovery; rs,
Spearman’s rank correlation coefficient
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Figure 39. Associations between RER during the 30MTW
and muscle oxidative capacity. 30MTW, 30-min treadmill
walk; RER, respiratory exchange ratio; RER L23, average
RER over the last 23 min of walk; RER L5, average RER
over the last 5 min of walk; RER L1, average RER of the last
1 min of walk; PCr, phosphocreatine; kPCr s-1, rate constant
of PCr recovery; rs, Spearman’s rank correlation coefficient
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Figure 40. Association between VO2 Peak normalized to total
mass and lean mass and oxidative capacity. VO2 peak, oxygen
consumption; PCr, phosphocreatine; kPCr, s-1, rate constant of PCr
recovery; rs, Spearman’s rank correlation coefficient
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Table 10. Spearman’s Rho correlation coefficients
∆PCr
Muscle Oxidative Capacity
-1
0.46
(0.30)
-.018 (0.71)
Oxygen Deficit (s )
-1
0.75 (0.07)
-0.64 (0.14)
EPOC (s )
0.75 (0.07)
-0.64 (0.14)
RER L23
0.71 (0.09)
-0.68 (0.11)
RER L5
0.70 (0.09)
-0.74 (0.07)
RER L1
-1
-1
-0.52 (0.20)
0.14 (0.75)
VO2 Peak (mL∙kg ∙min )
-0.62 (0.11)
0.64 (0.10)
VO2 Peak (mL∙kg-1 lean∙min-1)
-0.62
(0.11)
Oxidative Capacity
Data are rs (p-value), bolded values are from aims; PCr, phosphocreatine;
EPOC, excess post-exercise oxygen consumption; RER, respiratory exchange
ratio; RER L23, average RER over the last 23 min of 30MTW; RER L5,
average RER over the last 5 min of 30MTW; RER L1, average RER of the
last 1 min of 30MTW; VO2, oxygen consumption.
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CHAPTER 5
DISCUSSION
The purpose of this study was to begin to quantify the links between muscle
energetics the whole-body energetic response to daily-living type activity (30MTW). The
aims of this study were to determine whether the oxygen deficit at the beginning of
whole-body exercise was associated with the rate of muscle non-oxidative ATP at the
onset of contractions (∆PCr), and whether whole-body EPOC, RER, and VO2 peak were
associated with muscle oxidative capacity. Our hypotheses were that there would be a
positive association between muscle ∆PCr and O2 deficit, a negative association between
muscle oxidative capacity and EPOC as well as RER, and a positive association between
muscle oxidative capacity and VO2 peak.
The vastus lateralis muscle was selected for this study because it is a large,
commonly-studied muscle that plays an important role in ambulation (during which the
whole-body measurements were taken) as well as mobility-related function (22, 76, 86).
As no muscle works in isolation, the evaluation of a single muscle is generally completed
to gain information about a muscle group, the muscular system, or an organism as a
whole. The question here was: Are the energetic characteristics of a single muscle (vastus
lateralis) indicative of corresponding characteristics of whole-body energetics? The
results presented here suggest that they are.
While attempts were made to maximize the similarity between the muscle and
whole-body exercises, single-leg knee extension contractions and treadmill walking are
still fairly disparate activities. We believe this gives more weight to the associations
presented here, and suggests that the energetic variables described are not just indicators
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of task performance, but underlying physiological function. The relative similarity of the
participants- all young (25-35 years) healthy males who were not highly trained- should
also add weight to the strength of associations, as a study population with a larger spread
of characteristics would increase the chance that correlations are driven simply by group
based differences.
Muscle and Whole-body Non-oxidative Energy Use are Related at the Onset of
Exercise
In Aim 1, we explored the relationship between non-oxidative energy use at the
muscle (∆PCr) and whole-body (oxygen deficit) levels. For whole-body exercise, the
30MTW was used as it is a light-moderate intensity exercise, similar to what a person
may perform during free-living walking to the store or going to work. Low-intensity,
isotonic contractions were selected for the muscle contraction protocol because we
believed this mode of contraction to be most similar to the type of muscular work
performed during walking. To approximate the intensity of muscle contractions to those
occurring during the 30MTW, only the first 2-min stage of the ramp protocol was used in
the calculation of ∆PCr. It should be noted, however, that while the speed of the 30MTW
was the same for all participants (1.3 m∙s-1), the intensity of the first stage of the ramp
was set relative to each individual’s maximal force output (6% MVIC).
The magnitude of ∆PCr was associated with oxygen deficit (rs = 0.46). This result
suggests that individuals who were more reliant on PCr (a non-oxidative energy source)
at the onset of knee extensor contractions were also more reliant on non-oxidative energy
sources (PCr and glycolysis) at the beginning of whole-body exercise, such as walking. It
is not clear whether greater non-oxidative reliance is due to an enhanced ability to
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produce energy non-oxidatively, or a limited ability to rapidly increase oxidative energy
production. In support of the former, studies have shown that blocking PCr breakdown
and glycolysis in different preparations of isolated muscle leads to faster oxygen uptake
kinetics (41, 42, 44, 59). Additionally, the speeding of uptake kinetics (i.e., the shortening
of oxygen deficit) that occurs with training has been shown to precede changes in muscle
oxidative capacity measured by citrate synthase activity (89). However, the latter is
supported in this study by the negative association observed between ∆PCr and muscle
oxidative capacity (rs = -0.62), as well as VO2 peak normalized to lean mass (rs = -0.62),
suggesting that individuals with a greater capacity to increase oxidative energy
production relied less on PCr. Surprisingly, muscle oxidative capacity was not associated
with oxygen deficit (rs = -0.18), which in addition to the other research cited here,
suggest that oxygen deficit is a product of a great number of factors and controls that
warrants further investigation.
Although oxygen concentration (PO2) in muscle at rest is much higher than what
is required for resting oxidative energy production, potentially 50-100 fold, how quickly
PO2 becomes limiting is unclear and likely dependent on exercise intensity (68). It may
be the case that during light intensity, whole-body exercise the increase in oxygen uptake
is affected more by the ability of the body to deliver oxygen and nutrients than by the
inherent characteristics of the muscle, an idea that is a subject of debate in the field (90).
The fact that oxidative capacity in the VL is associated with greater reliance on PCr at the
onset of muscle contractions but not at the onset of walking (oxygen deficit), could also
be due to lower oxidative capacity in other ambulatory muscles. These complexities may
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explain why the correlation coefficient for the association between ∆PCr and oxygen
deficit was lower than other relationship shown here.
Muscle and Whole-body Oxidative Energy Use are Related
The relationship between oxidative energy use at the muscle (oxidative
capacity) and whole-body levels (EPOC, RER, and VO2 peak) was examined in Aims
2.1-3. The isokinetic muscle oxidative capacity protocol was selected because it causes a
significant depletion of PCr without greatly disturbing pH, or blood flow (as maximal
isometric protocols do), which should help ensure that the post-contraction rate of PCr
recovery represents the maximal ability of the muscle to generate ATP oxidatively (87).
Given that muscle cells are responsible for up to 90% of oxygen consumption during
exercise and 30% during rest, the two levels are inextricably linked (110). Additionally,
the same physiological factors - mitochondrial content, capillary density, and
concentration of oxidative enzymes - are major determinants for both the independent
and dependent variables (13, 31, 90, 100). Still, the relevance of a single muscle’s
oxidative capacity to whole-body energetics is not evident enough that it may be
assumed. The correlations presented here shed light on the strength and direction of these
relationships.
Muscle Oxidative Capacity is Associated with EPOC
Muscle oxidative capacity was associated with the time constant of EPOC (rs = 0.64), suggesting that individuals who have a higher maximal rate of muscle oxidative
energy production may return to resting VO2 levels more rapidly following exercise. The
time constant for EPOC represents the time it takes for oxygen consumption to recover
by 63% following exercise, and reflects of the body’s ability to return to homeostasis.
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Metabolic recovery after exercise is dependent on restoration of metabolite
concentrations to resting levels, and re-synthesis of PCr makes up a substantial portion of
EPOC (38). It is then reasonable to expect that the ability to replenish PCr quickly (via a
high oxidative capacity) would lead to a faster recovery (a lower EPOC time constant).
However, this would imply that either muscles work at or near their oxidative capacity
during recovery from low-intensity work, or that a lower oxidative capacity is related to
lower rates of oxidative energy production even at submaximal intensities (during
recovery). It should be noted that the beneficial effects of training on muscle, such as
mitochondrial biogenesis, increased cytochrome oxidase activity, and greater activation
of mitochondrial complexes has been demonstrated to lead to greater improvements in
oxygen deficit than EPOC (109). In light of which, the authors pointed out that EPOC is
less dependent on muscle oxygen consumption than deficit, as it also reflects the slowly
decreasing oxygen consumption of the heart and lungs among other variables. It is then
surprising that we found in this study a strong relationship between muscle oxidative
capacity and EPOC, but not oxygen deficit.
An enhanced ability to produce energy oxidatively may also lead to a lesser
reliance on PCr at the onset of activity, as observed in Aim 1, thus decreasing the amount
of PCr that needs to be replenished in recovery. Our analysis shows that the strongest
association among our variables was the positive linear relationship between ∆PCr and
EPOC (rs = 0.75). This relationship indicates that those who deplete PCr to a greater
degree at the onset of exercise take longer to recover following exercise, and that reliance
on non-oxidative energy production at the beginning of exercise may be a more important
determinant for exercise recovery than oxidative capacity. This is not surprising given
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that EPOC was originally termed oxygen debt and was believed to only consist of
‘repayment’ of oxygen deficit; an idea that has since been disproven, but was not entirely
baseless (38).
Muscle Oxidative Capacity is Associated with RER
Muscle oxidative capacity was associated with the mean RER from the entire
steady-state (RER L23, rs = -0.64), the last 5 min (RER L5, rs = -0.68), and the last
minute (RER L1, rs = -0.74) of the 30MTW. These correlations suggest that individuals
with a higher oxidative capacity relied more on fat oxidation than those with a lower
oxidative capacity throughout the 30MTW. In the example plot in Fig. 27, RER takes
longer to plateau than does VO2, suggesting that RER changes over the course of VO2
steady-state; a similar pattern was observed in all participants. It is interesting to note that
the association between muscle oxidative capacity and RER appears to strengthen when
the RER mean was calculated from the latter portions of the test, especially considering
that the group means for RER L23, L5 and L1 were not significantly different (Table. 4).
Oxidative capacity is more than just a measure of the muscle’s ability to replenish
PCr, it is an indicator of the tissue's ability to produce ATP through oxidative metabolism
(87). Fat is the preferred fuel source for oxidative metabolism at rest and during lowintensity activities. Carbohydrate is the predominant fuel source at higher intensities, at
least partially because it can be metabolized at a faster rate (55, 90). In this way, cells rely
more on fat until the energy demand is too great to be met by its slower rate of oxidation.
A higher oxidative capacity may keep energy demand from reaching this point, which
would explain the association between oxidative capacity and RER. Likewise, an
adaptation seen with training is an increase in fat oxidation across relative intensities (13,
82

31). The results here suggest that this effect may be evident even at relatively low
intensities (i.e., the 30MTW). It is also important to consider that the 30MTW walk
represented a different relative intensity (as a percentage of VO2 peak) across
participants. The relationship between muscle oxidative capacity and RER may be a
function of the higher VO2 peak, and therefore lower relative intensity, in individuals
with a higher oxidative capacity (14).
A surprising finding was that ∆PCr had a higher correlation with RER (L23 rs =
0.75, L5 = 0.71, and L1 = 0.70) than muscle oxidative capacity did. Given that ∆PCr is a
purely anaerobic measure, and RER (at steady-state) is a purely aerobic measure, the
reason for this relationship is not clear. However, individuals who had a greater ∆PCr
also had a lower VO2 peak per lean mass (rs = -0.62); so the relationship between ∆PCr
and RER may also be an artifact of the relative intensity of the 30MTW. Other factors,
such as energy balance and dietary consumption, can also affect RER, however this was
controlled for by the standardized lunch consumed 2.5 hr. before the 30MTW by all
participants (80).
Muscle Oxidative Capacity is Associated with VO2 Peak
Muscle oxidative capacity was associated with VO2 peak relative to lean mass (rs
= 0.64), but not VO2 peak relative to total mass (rs = 0.14). This suggests that individuals
with a higher oxidative capacity tend to have a greater ability to increase whole-body
oxygen consumption per unit of lean tissue, but not per unit of total mass (fat and lean
mass); meaning that variations in body fat between participants confound this
relationship, which is not surprising given the relatively low metabolic rate of adipose
tissue (32). This is in contrast to several previous studies that have found an association
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between VO2 peak normalized to total mass and muscle oxidative capacity measured via
in vitro respiration (r2 = .81-.89) (111), near-infrared spectroscopy (r2 = .57) (63), and 31PMRS (r2 = .54) (2). Discrepancies in findings may be due a smaller range in body
composition (63), or greater number of participants (2, 111), which may have negated or
balance the impact of inter-individual differences in body composition. In another study
(58), an inverse relationship was shown- a higher VO2 peak was associated with a slower
PCr recovery- but this was possibly due to sex based differences in VO2 peak (women
tend to have a higher percentage of body fat). It has been suggested that VO2 normalized
to total body mass may have greater implications for exercise performance, while VO2
normalized to lean mass (more metabolically active tissue) is more relevant when
discussing physiological capacity (39).This is logical as an increase in body fat would
increase the workload of a graded treadmill test, but not mechanical function or oxidative
capacity of the muscle.
Maximal oxygen consumption is dependent on the ability of the pulmonary and
cardiovascular systems to deliver oxygen to the body’s cells, the capacity of those cells to
use oxygen to generate ATP, and the rate at which ATP production can be stimulated.
However, studies that have measured oxidative capacity in isolated muscle cells suggest
that the summed maximal oxygen consumption of all the body’s muscle cells is greater
than what has been measured at the whole-body level (5, 10). This suggests that oxygen
consumption is likely limited by the ability of the body to deliver oxygen to the muscle,
not the muscle’s oxidative capacity. Despite this, ours and other studies have shown
evidence of a positive relationship between muscle oxidative capacity and peak oxygen
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consumption (3). It is reasonable then, that although muscle oxidative capacity may not
be the factor limiting VO2 peak, it can be used as an indicator for aerobic fitness.
It should be noted that performance in a graded exercise test and the VO2 peak
value obtained is dependent on participant motivation, nutritional status, the testing
environment, exercise experience, and testing modality (e.g., treadmill, cycle ergometer
.etc.), among other factors (55, 90). If not well controlled, these factors can lead to
greater variability and lower accuracy in this measure. In addition, performance of a
graded exercise test may not be possible for certain populations, including the elderly.
Due to this, Alexander et al., 2003 (4) suggest that submaximal measures of oxygen
consumption such as the oxygen deficit and EPOC may be more suitable indicators of
aerobic fitness in these populations. This is one of the reasons that Aims 2.1 and 2.2
focused on submaximal whole-body measurements that minimize or eliminate some of
these issues in identifying the link between muscle and whole-body energetics.
Limitations
This study was completed on a small number of participants, who were all male,
younger, relatively healthy, and not representative of the population as a whole. This
could be easily remedied through a study with a greater number of participants including
both sexes and multiple age groups. With the 7 or 8 participants involved in these
analyses, a Spearman’s rs greater than ~0.76 would have been necessary to reach the
generally accepted alpha level of significance of p < 0.05. No associations detected here
met that criterion. Again, a greater number of participants could help with this. Since this
was an exploratory study, associations were also assessed using Pearson’s and Kendall’s
methods and these data can be found in Appendix E. Pearson correlations resulted in
85

considerably higher coefficients and lower p-values and the opposite was true for
Kendall’s. Oxygen consumption data is inherently subject to a fair amount of variability
and noise. As a result completing several 30MTWs and averaging the oxygen
consumption measurements would have been useful for increasing the signal to noise
ratio. A study by Benson et al. in 2017 (11), specifically suggests averaging four exercise
bouts when analyzing the oxygen deficit, and even proposed a minimally important time
constant difference of ~5 s (which was not found in our study). As mentioned in the
results, the timing of the end of the 30MTW was not recorded for two participants, and
thus had to be estimated. The first four participants were allowed phone access during
recovery, which may have unintentionally increased VO2 during this period. Several
participants who were not allowed phone access during recovery were close to falling
asleep post-walk, which may have unintentionally decreased their resting VO2. If this
study were repeated, better control of the environment, wakefulness of participants, and
timing of the whole-body energetic measurements would be desirable. To account for the
thermic effect of food and other dietary responses a standardized lunch was fed to
participants for all visits. This lunch, however, may not have the same effect on
participants with different body sizes, free-living diets, and energy expenditures.
Individualization of future standardized meals may be more effective if robust methods to
elicit similar responses can be implemented.
Summary
The goal of this study was to investigate both non-oxidative and oxidative
energetic characteristics at the muscle and whole-body levels. Associations were
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observed between ∆PCr and oxygen deficit, EPOC, and RER; as well as between muscle
oxidative capacity and EPOC, RER, and VO2 peak in a group of healthy, young males.
These promising results can be extended by studies evaluating the same
relationships with participants of different ages, sex, and habitual physical activity levels.
If strong and significant associations are consistently demonstrated, then researchers can
begin to make inferences about whole-body energetics from muscle measurements, and
vice versa. There is already a well-established relationship between whole-body
energetics - including oxygen deficit, EPOC, and VO2 peak, and energy cost of walking –
and performance and fatigability during mobility test (4, 9, 92, 98, 99). Therefore, wholebody energetics may serve as an intermediary point between muscle energetics and
mobility-related function. This connection could potentially help researchers understand
the role muscle energetics may play in the decline in mobility-related function (Fig. 41).
This would be particularly useful in the study of aging and physical inactivity, which is
associated with a decline in knee extensor muscle oxidative capacity (36), as well as a
decline in walking speed, postural control, and the ability to transition from sitting to
standing or walking (9, 11, 75).

Figure 41. Pathway connecting muscle energetics to mobility-related
function. Adapted from Fig. 2.
In conclusion, this study provides preliminary evidence that muscle energetics are
indicative of the oxygen deficit, RER, and EPOC in response to daily-living type
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exercise. This is a novel finding that links muscle and whole-body energetics despite their
being measured using different techniques, in different settings, and in response to
different forms of exercise. Given the practicality of indirect calorimetry measurement
during mobility tasks, this link can be exploited to improve our understanding of the
energetics of movement.
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APPENDIX A
INFORMED CONSENT FORM
Consent Form for Participation in a Research Study University of Massachusetts
Amherst
Researcher(s): Michael Busa, Ph.D., Jane Kent, Ph.D., John Sirard, Ph.D., John
Staudenmayer, Ph.D., Greg Petrucci, Christopher Hayden
Study Title: Room Calorimetry: Energetics of Fatigue Pilot
Funding Agency:
1.

WHAT IS THIS FORM?

This form is called a Consent Form. It will give you information about the study so you
can make an informed decision about participation in this research. It will also describe
what you will need to do to participate and any known risks, inconveniences or
discomforts that you may have while participating. We encourage you to take some time
to think this over and ask questions now and at any other time. If you decide to
participate, you will be asked to sign this form and you will be given a copy for your
records.
2.

WHO IS ELIGIBLE TO PARTICIPATE?

We are recruiting 8 people to participate in this study. All participants will be free of
acute and chronic neurological, musculoskeletal, metabolic, cardiovascular or other major
diseases or injuries, and will not have a pacemaker. Additionally, a physician must not
have told the participant that they should refrain from physical activity. Additionally,
they will not have had surgery in the previous 6 months that would impact their ability to
perform light-to-moderate physical activity. Participants will consist of 8 males between
the ages of 25-40 years.
3.

WHAT IS THE PURPOSE OF THIS STUDY?

The goals of this study are to: 1) Demonstrate that reliable data can be obtained from the
Room Calorimeter during 24-hour visits. 2) Determine the sensitivity of the Room
Calorimeter system to better understand its capacity and constraints. 3) Compare energy
expenditure values from the Room Calorimeter to energy expenditure and physical
activity estimates from several research-grade accelerometers. 4) Identify the effects of a
treadmill walk on the energetics of healthy young sedentary individuals. 5) Collect data
that will assist us in developing hypotheses in the areas of exercise, exercise recovery,
mechanical and metabolic interactions, and physical activity assessment.
4.
WHERE WILL THE STUDY TAKE PLACE AND HOW LONG WILL IT
LAST?
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The study will be conducted in the Human Testing Center and the Human Magnetic
Resonance Center (S360 and S230 Life Science Laboratory Building), in the Institute for
Applied Life Science (IALS) at the University of Massachusetts Amherst. This study is
expected to last 18 months. If you participate, you will take part in 4 testing visits; 2
visits will last approximately 24 hours each, 1 visit will last 4.5 hours, and 1 visit will last
2.5 hours.

5.

WHAT WILL I BE ASKED TO DO?

Prior to each visit
We ask that the day prior to each visit you avoid alcohol use and strenuous
exercise. The day of each visit we also ask that you avoid consuming caffeine.
Visit 1 (4.5-hour Baseline Habituation visit)
This visit will be conducted in the Room Calorimeter suite of the Human Testing Center
in IALS, with the exception of height and weight measures and the body composition
scan, which will be completed across the hall in the Exam Room. The Room Calorimeter
is an instrument built as a standard room and used to measure oxygen consumption and
carbon dioxide production by humans in a typical living setting. It is about the size of a
large bedroom and contains a TV, toilet, sink, chair, desk, and treadmill. There are two
ports (sealed openings in the wall) by the entrance to the room that are used for passing
food and other material into the chamber without opening the doors. The room has a
window to the outside of the building as well as to the inside of the lab. Both windows
are equipped with blinds for privacy. For the first visit, the Room Calorimeter door will
not be shut and the instrument will not be running. This habituation visit will allow you
to become familiar with the facility, and promote easier acclimation during following
visits.
You will be fed a small lunch (~400 calorie meal replacement bar) which will allow us to
compare energetic response between participants, there will be several options to choose
from. You will be allowed 30 minutes to complete your lunch. You will be oriented to the
Room Calorimeter, and shown the button that blurs the cameras in case you are in need
of private time (i.e., changing clothes or using the toilet). Video will be recorded during
this study, this button will disable recording and live viewing through the camera system.
Video access is restricted to Human Testing Center personnel and can only be accessed
using an onsite computer. You will also be shown how to work the exit door (a simple
push latch). Your height, weight, age, and gender will be recorded, and an iDXA body
scan will be completed by a certified technician.
iDXA Scan
An iDXA (dual-energy X-ray absorptiometry) scan, also called a bone density scan, is a
common technique used to measure bone density. It can also be used to estimate body
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composition (% fat and % lean mass), as in this study. The DXA scan will involve lying
on a padded table while a scanning arm passes over you. This test will last no longer than
30 minutes. This completely painless procedure is easily performed and involves minimal
radiation exposure.
In accordance with Massachusetts Department of Public Health guidelines, iDXA scans
are performed by a certified technician and prescribed and reviewed by Dr. Stuart
Chipkin (University of Massachusetts Amherst, 240 Thatcher Rd., Amherst, MA 01003).
During the scan you will be exposed to low amounts of ionizing radiation; these levels
are approximately 2% of that you would be exposed to during a chest X-Ray and less
than you would receive from a cross-country airplane flight.
From this study, it may be found that you have ‘normal bone density’, ‘low bone
density’, ‘osteoporosis’, or ‘severe osteoporosis’. If your results indicate anything
OTHER THAN ‘normal bone density,’ you will receive a follow-up letter from the
research team. In this case, it will be recommended that you follow up with your personal
physician. With your written permission, the data that we collect will be made available
to your physician for their review and interpretation. These results are not diagnostic and
do not indicate a specific risk of bone fracture. This can only be determined by a clinician
when also accounting for other factors.
Prior to this scan, you will be asked a series of screening questions to determine if
undergoing an iDXA would pose any undue risk. As this is for your protection, it is of the
utmost importance that you answer completely and to the best of your knowledge. While
the risk with this procedure is extremely low, your safety is paramount.

Two hours after lunch you will be outfitted with the Parvo Medics TrueOne 2400
Metabolic System, which consist of a mask connected to hoses that collect expired air,
filters it, and runs it through a gas analyzer on a stationary cart. You will be asked initiate
the fitting of the mask and a researcher (while wearing gloves and a face shield) will step
in to complete it. You will also be asked to outfit yourself with several research-grade
accelerometers (similar to Fitbits); an ActivPal (dominant thigh), a StepWatch (dominant
ankle), a SenseWear Armband (upper arm), and an ActiGraph (non-dominant wrist).
Next, you will be asked to complete 30 minutes of walking on a treadmill. The treadmill
will be flat and the speed will be increased over the first 30 seconds of this walk until 1.3
m∙s-1 is reached. At that point, you will be asked if you think you can maintain that speed
for 30 minutes. If you cannot, the treadmill speed will be reduced in small (0.045 meters
per sec) increments every 10 seconds, until you are confident you are at a speed that you
can maintain for 30 minutes. At minutes 7, 17, and 27, the incline of the treadmill will be
increased to 3% for 1 minute, in order to provide a slight challenge and to simulate a hill
that you might encounter in everyday life. After 1 minute, the incline will be returned to
level. At minute 28, you will be asked to rate your exertion on a scale of 0 to 10. The
scale is a simple visual rating system that you can point to during the walk, with a 0
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meaning “nothing at all” and a 10 meaning “maximal” exertion. During the final 30
seconds of the walk, the treadmill will be gradually slowed to 0.4 meters per second
before stopping.
During this treadmill walk, you will be connected to the emergency stop safety cord and
instructed on how to use the treadmill safely. At all times, the treadmill will be controlled
by study staff. This treadmill walk will be completed on the treadmill in the Room
Calorimeter.
Next, you will be asked to sit quietly for a 2-hour, passive recovery period during which
time you will be allowed to watch TV, read, or use any mobile devices you may have.
You will wear all of the same study devices from the walk during this recovery period.
After this passive recovery, you will remove the facemask and all other monitors. You
will then be given an ActiGraph (a step counter), which you will be asked to wear on
your non-dominant wrist for a seven-day lead-up to your first 24-hour visit to the Room
Calorimeter. You will also be asked to take pictures of your meals and any snacks for 3
days prior to your second visit. You will be asked to complete this task and send us the
pictures via email at least two days before your 24-hour visit.

Visits 2 and 3 (24-hour Room Calorimeter Stays):
You will be asked to complete two visits of 24 hours each in the Room Calorimeter. They
will be completed on separate days within one month of each other. These visits will be
conducted in the Room Calorimeter suite of the Human Testing Center of IALS.
You will be asked to arrive in the evening (~7 pm). Upon arrival, you will again
outfit yourself with Fitbit-like devices consisting of an ActivPal (placed on your
dominant thigh), a StepWatch (dominant ankle), a SenseWear Armband (upper arm), and
an ActiGraph (non-dominant wrist). You will be asked to keep these on for the duration
of the study unless you are changing your clothes.
The Room Calorimeter is an instrument that allows us to measure your oxygen
consumption. This measurement requires the door to the room calorimeter to remain
sealed throughout the study. You will be free to leave at any time during the study if you
no longer wish to be a participant. You should simply notify the study staff and press on
the exit latch to leave the room. Your entire stay will be video recorded through the
cameras installed in the calorimeter, sound will not be recorded. We will use these
recording to annotate your stay and the timing of certain activities you will perform. You
can stop the video from recording at any time by pressing a button on the wall. We will
request that you do this anytime you wish to change, use the restroom, or are in need of
private time.
A walkie-talkie (and extra batteries) will be provided and there will be a CPR- and First
Aid-certified research staff member in communication with you at all times. A schedule
will be given to you, and either the walkie-talkie or the intercom system will be used to
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provide further instructions during your stay. You will then enter the Room Calorimeter.
The schedule is as follows:
7:00 PM:

Enter Room Calorimeter and quick review of facilities and procedures

7:15 PM:

Dinner (served through the food port)

8:00 PM:

Free time until you wish to sleep

12:00 AM:

Time by which you must be in bed

8:00 AM:

Wake up, get out of bed

8:15 AM:

Scripted Activities (see below)

9:15 AM:

Breakfast (served through the food port)

9:45 AM:

Downtime

11:30 AM:

Lunch

12:00 PM:

Two hours of passive (resting) free time

2:00 PM:

30 treadmill walk as described above (without Parvo unit)

2:30 PM:

Passive recovery

7:00 PM:

Exit Room Calorimeter

The “Scripted Activities” will be as follows
Strip bed; make bed (10 min)
Sit (5 min)
Fold basket of laundry (towels; 10 min)
Sit (5 min)
Vacuum floor (10 min)
Sit (5 min)
Wash and dry dinnerware and silverware (10 min)
Sit (5 min)

You will be asked to complete 1,200 steps in the Room during your downtime (before
2:00 pm). The activity tracker on your wrist will display the step count for you. Breakfast
and dinner will be based on the meal pictures you provided us. Lunch will be the same
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for all four visits. After exiting the Room Calorimeter, you will remove all devices prior
to leaving.
Research staff will be present in the Human Testing Center for the entirety of the study
(including during your sleep time).
Visits 4 (Exercise Testing):
For Visit 4 you will be given a meal replacement bar ahead of time to take home,
identical to the other visits, which we ask you consume in the morning two hours before
your visit. That morning you will also be asked to:
1. Wear loose-fitting clothes (jogging attire, shorts, training shoes, etc.)
2. Avoid eating or drinking anything but water and the meal provided.
3. Avoid alcohol, tobacco, and coffee.
4. Avoid exercising.
5. Try to get a good night's sleep the night before.
Upon arriving at the Human Magnetic Resonance Center in the Life Sciences Lab
Building, you will meet with the MR Operator to review the MR Safety Form. Before
entering the magnet room, you will remove any jewelry, empty your pockets, and walk
through a metal detector. You will then be escorted to the MR scanner and positioned on
your back with your dominant leg on top of our custom-built leg exercise apparatus,
which is similar to a knee extension machine one might use at a gym. The lower leg
(shin) will be strapped to the apparatus just above the ankle and at the knee using Velcro
straps. Inelastic straps will also be secured over your hips to prevent unwanted movement
during the muscle contractions, and a specially-designed copper coil encased in a plastic
box will be secured over your thigh muscles using Velcro straps. This coil will be used to
measure changes in muscle biochemistry during the contractions.
Lastly, headphones will be provided to limit the amount of noise from the MR scanner,
and to enable clear and constant communication between you and the investigators. We
will talk with you and explain each set of measures as we go along. These measures are
described next.
After you have been secured to the leg-exercise apparatus, we will position you in the
center of the scanner and “tune” the magnet to your thigh muscles. We will then take
measures of your muscle biochemistry while you lay quietly for about 10-15 minutes.
Next, you will complete 2-3 maximal static contractions, each lasting 3-4 seconds, to
determine your strength and to establish the workloads that will be performed during the
incremental protocol. About 1 minute of rest will be given between each of these
contractions. You will then be familiarized with the dynamic contractions (1 contraction
every 2 seconds) by performing a few sets of 2-3 contractions. Once you are comfortable
with the dynamic contraction procedures, you will perform a 24s maximal isokinetic
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contraction protocol. This will consist of one maximal dynamic contraction every two
sections, after which you will rest quietly without moving for up to 10 minutes.
Next, you will perform the study protocol, which involves 4 stages of dynamic knee
extensions. These contractions are most similar to the types of contractions that would be
performed on an exercise machine at a fitness gym. Each stage will last 2 minutes, with 1
contraction being performed every 2 seconds. Workload will increase with each stage,
starting at a light intensity and increasing to moderately-high intensity. Following the 4th
stage of the protocol, recovery measures will be collected while you rest quietly without
moving for up to 10 minutes. Following the MR measures, you will be brought from the
Human Magnetic Resonance Center to the Human Testing Center. In the human testing
center, you will have your blood pressure taken and will be prepped to complete a graded
exercise test to determine your maximal volume of oxygen consumption (VO2 max).
VO2 max tests are one of the most widely used evaluations in the world of exercise
physiology and are utilized to evaluate aerobic fitness. During the test, you will be
instrumented with the same Parvo Metabolic Cart utilized during the baseline visit as
well as a chest strap Polar heart rate monitor. We will be using the BSU/Bruce Ramp
treadmill protocol as described by Kaminsky and Whaley (1998). This protocol is
designed to be better suited for a wide range of populations through its use of a gradual
ramp in intensity, allowing for longer walking periods and smaller transitions between
stages. The test begins with a paced walk and gradually increases in speed and/or incline.
Heart rate, oxygen consumption, and Rating of Perceived Exertion (RPE) will be
monitored throughout the test. The test will be terminated when you feel you cannot
continue or if the researcher determines the test should end due to maximal intensity
being reached safety concerns or equipment malfunction. A typical test will last between
8-12 minutes depending on your fitness level. After Completion of the VO2 max test, you
will have equipment removed and will complete a short cool down.
6.

WHAT ARE MY BENEFITS FOR BEING IN THIS STUDY?

It is important that you understand that we anticipate no direct benefit to you from your
participation in this study.
7.

WHAT ARE MY RISKS OF BEING IN THIS STUDY?

Physical well-being
General Exercise Precautions: During any type of exercise, there are slight health risks,
along with the possibility of fatigue, cardiovascular events, muscle soreness, and falls.
Study personnel will monitor your performance. The testing will be terminated if you
show any signs of poor exercise tolerance (i.e. extreme fatigue, shortness of breath, chest
pain, dizziness, etc.).
VO2 Max Testing: Risk include, but are not limited to, abnormal blood pressure, chest
pain, shortness of breath, fainting, disorders of the heartbeat (too rapid, too slow or
unusual beats) and in rare instances, heart attack. Every effort will be made to avoid or
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minimize such occurrences through screening and continuous observations during testing.
Emergency equipment and trained personnel are available to deal with unusual situations
which may arise.
DXA Scan: Scans expose you to low-levels of X-Ray ionizing radiation. The risk
associated with this type of scan is very low, less than that of a New York to Los Angeles
flight. You will be screened for the possibility of lifetime limit for radiation exposure. If
you indicate that you have reached their lifetime limit for being exposed to ionizing
radiation, then no scan will be performed.
Magnetic Resonance Spectroscopy (MRS) and Imaging (MRI): The United States Food
and Drug Administration (FDA) has established guidelines for magnetic field strength
and exposure to radio waves, and we carefully observe those guidelines. Some people
may feel uncomfortable or anxious during the MRS testing procedures. If this happens
you may ask to stop the study at any time and we will take you out of the MR scanner
(magnet). On rare occasions, some individuals might feel dizzy, get an upset stomach,
have a metallic taste, feel tingling sensations, or experience muscle twitches. MRS poses
some risks for certain people. Individuals with a pacemaker or some metal object inside
the body will be excluded from this study because of the strong magnets used for these
studies. Another risk is a metallic object flying through the air toward the magnet and
hitting the participant. To reduce this risk we require that all people involved with the
study remove all metal from their clothing and all metal objects from their pockets.
Nothing metal can be brought into the magnet room at any time. Also, once you are in the
magnet, the door to the room will be closed so that no one from outside accidentally goes
near the magnet.
Psychological well-being
During the 24-hour stay, you will be asked to stay within the Room Calorimeter, which is
very similar to a hotel room. Because of the duration and lack of general outside contact,
you may become bored. To minimize this you will have access to all modern means of
personal communication and entertainment (i.e. phone, computer, TV, internet access).
Visitors will also be allowed during your downtime, however, they must remain outside
of the chamber. Being in the Room Calorimeter may make you feel uncomfortable,
anxious, or claustrophobic, although multiple windows in this space minimize this
possibility.
You may be bothered by feelings of claustrophobia during MRS testing. Unlike the case
for brain imaging, you will be positioned feet-first in the magnet, and your head will
remain near the opening of the magnet. These features minimize the problem of
claustrophobia, but anyone reporting significant claustrophobia who wishes to be
removed from the scanner will be removed immediately.
8.

HOW WILL MY PERSONAL INFORMATION BE PROTECTED?
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All digital files will be maintained on an encrypted, secure, password-protected server.
None of your personal information will be included in these files. Rather, we will give
them a code. The file linking your identity and code will be kept in a locked drawer in a
locked room. We expect the data collection for this study to last approximately 1.5 years.
All electronic files containing identifiable information will be password-protected. Video
recordings will be housed on a secure data server and agents of the sponsor may be able
to view these on-site at UMass. At the conclusion of this study, the researchers may
publish their findings. Information will be presented in summary format and you will not
be personally identified in any publications or presentations.
9.
WHAT IF THERE IS AN UNEXPECTED FINDING ON MY IDXA OR
MRI SCAN?
The investigators for this research project are not licensed or trained diagnosticians or
clinicians. The testing performed in this project is not intended to find abnormalities, and
the images or data collected do not comprise a diagnostic or clinical study. However,
occasionally in the process of research, investigators may perceive an abnormality, the
health implications of which may not be clear. When an unexpected finding is noted,
UMASS Amherst researchers will consult with a radiologist (for MRI) or physician (for
iDXA). If the radiologist/physician determines that an additional inquiry is warranted,
the researcher will then contact you regarding the radiologist’s/physician’s opinion of the
unexpected finding(s).
In such a case, you are advised to consult with a licensed physician to determine whether
further examination or treatment would be prudent. Although the images collected for
this research project do not comprise a diagnostic or clinical study, the images can be
made available to you for clinical follow-up. The costs for any care that will be needed to
diagnose or treat an unexpected finding(s) would not be paid for by University of
Massachusetts, Amherst. These costs would be your responsibility. If you have further
tests done by your licensed physician, those results will then become part of your medical
record, which may affect your current and future health or life insurance. Regardless of
the health implications, the discovery of an unexpected finding(s) may cause you to feel
anxious or worried. You may wish to talk to your physician or a qualified mental health
clinician. You can contact the Center for Counseling and Psychological Health (CCPH)
at (413) 545-2337 (Mon-Fri from 8-5pm) - on weekends or after 5pm, call (413) 5775000 and ask for the CCPH clinician on call. You can also contact the Psychological
Services Center at 413-545-0041 (Monday-Friday 8am-5pm) or psc@psych.umass.edu.
In a serious emergency, remember that you can also call 911 for immediate assistance.

10.
WILL I RECEIVE ANY PAYMENT FOR TAKING PART IN THE
STUDY?
Yes, you will be compensated in person for your participation in this study, in gift cards.
You will receive $25 for the baseline visit, $100 for each 24-hour visit, and $25 for the
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exercise testing visit. You will be paid at the end of each portion of the study. Payment
for the 24-hour stay will be prorated in six-hour increments. You will receive $25 for
each 6-hour block you stay in the study (e.g., those who drop out after 12 hours will
receive $50). You will receive the full $100 if and when you complete the full 24-hour
visit. Total possible compensation will equal $250.
11.

WHAT IF I HAVE QUESTIONS?

Take as long as you like before you make a decision about whether to participate. We
will be happy to answer any question you have about this study. If you have further
questions about this project or if you have a research-related problem, you may contact
the principal investigator, Professor Jane Kent (413-545-9477; jkent@umass.edu). If you
have any questions concerning your rights as a research subject, you may contact the
University of Massachusetts Amherst Human Research Protection Office (HRPO) at
(413) 545-3428 or humansubjects@ora.umass.edu.
12.

CAN I STOP BEING IN THE STUDY?

You do not have to be in this study if you do not want to. If you agree to be in the study,
but later change your mind, you may drop out at any time. There are no penalties or
consequences of any kind if you decide that you do not want to participate.
13.

WHAT IF I AM INJURED?

The University of Massachusetts does not have a program for compensating subjects for
injury or complications related to human subjects research, but the study personnel will
assist you in getting treatment in the unlikely event that you are injured during the testing.
14.

CAN WE RECONTACT YOU?

May we contact you in the future to invite you to participate in additional studies like this
one?
Yes

NO

15.

SUBJECT STATEMENT OF VOLUNTARY CONSENT

When signing this form, I am agreeing to voluntarily enter this study. I have had a chance
to read this consent form, and it was explained to me in a language that I use and
understand. I have had the opportunity to ask questions and have received satisfactory
answers. I understand that I can withdraw at any time. A copy of this signed Informed
Consent Form has been given to me.
In no way does signing this consent form waive your legal rights nor does it relieve the
investigators, sponsor or involved institutions from their legal and professional
responsibilities.
Participant Signature
Print Name
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Date
By signing below, I indicate that the participant has read and, to the best of my
knowledge, understands the details contained in this document and has been given a
copy.

Signature of Person Obtaining Consent
Print Name
Date
EMERGENCY CONTACT
As a part of this study, you will be staying in the Human Testing Center for 24 hours. In
the event that you fall ill or become injured, please provide an emergency contact.
Emergency Contact Name
Phone Number
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APPENDIX B
PARTICIPANT SCREENING FORM
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APPENDIX C
VO2 PEAK TEST PROTOCOL
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APPENDIX D
PARTICIPANT 7 EPOC FIT DATA ADJUSTMENT FOR PHONE USE

A.

B.
Figure 42. Screenshot of the curve fitting analysis for 30MTW EPOC of participant
7. Data are VO2 fit over time from a single participant (pt7). Offy, volume of oxygen
consumption in mL∙kg-1∙min-1; offx, time in seconds; 30MTW, 30-min treadmill walk.
A.) Unadjusted fit of EPOC.
B.) Adjusted fit EPOC. Data points during documented times when the participant was
observed to be holding a cellular phone high in front of their face (red “x’s”) were
excluded from the fit. The results from this fit were used for analysis in this case. It is
likely that phone use in this manner occurred with earlier participants, as well. However,
the exact times of this use were not documented, and therefore, those data were not
removed from the analysis.
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APPENDIX E
CORRELATION COEFFICIENTS AND P-VALUES FROM PEARSON’S,
SPEARMAN’S, AND KENDALL’S TESTS

∆PCr vs.

Dependent Variable

∆PCr (mM)
Oxygen Deficit (s)
Oxidative Capacity
(s-1)
RER L23
RER L5
RER L1
EPOC (s)
VO2 Peak
(mL∙kg-1∙min-1)
VO2 Peak Lean
(mL∙kg-1 lean∙min-1)

Pearson
R
1.00
0.68
-0.73

P-value

0.75
0.80
0.76
0.57
-0.38

0.05
0.03
0.05
0.18
0.35

0.75
0.71
0.70
0.75
-0.52

0.07
0.09
0.09
0.07
0.20

0.62
0.52
0.59
0.62
-0.36

0.07
0.14
0.09
0.07
0.28

-0.61

0.10

-0.62

0.11

-0.43

0.18

Dependent Variable

Pearson
R
-0.73
-0.24
1.00

1.00
0.09
0.04

Spearman P-value Kendall
Rho
tau
1.00
1.00
1.00
0.46
0.30
0.33
-0.62
0.11
-0.43

Oxidative Capacity vs.
P-value Spearman P-value Kendall
Rho
tau
0.04
-0.62
0.11
-0.43
0.60
-0.18
0.71
-0.14
1.00
1.00
1.00
1.00

P-value
1.00
0.38
0.18

P-value

∆PCr (mM)
0.18
Oxygen Deficit (s)
0.77
Oxidative Capacity
1.00
(s-1)
RER L23
-0.65
0.11
-0.64
0.14
-0.43
0.24
RER L5
-0.76
0.05
-0.68
0.11
-0.52
0.14
RER L1
-0.90
0.01
-0.74
0.07
-0.59
0.09
EPOC (s)
-0.74
0.06
-0.64
0.14
-0.43
0.24
VO2 Peak
0.23
0.58
0.14
0.75
0.21
0.55
(mL∙kg-1∙min-1)
VO2 Peak Lean
0.63
0.09
0.64
0.10
0.43
0.18
(mL∙kg-1 lean∙min-1)
EPOC, excess post-exercise oxygen consumption; RER, respiratory exchange ratio; RER
L23, average RER over the last 23 min of walk; RER L5, average RER over the last 5
min of walk; RER L1, average RER of the last 1 min of walk; VO2, volume of oxygen
consumption.
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